OTHER PUBLICATIONS
| DOWNLOAD | TITLE | AUTHORS |
|---|---|---|
 |
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis | M. Lorentzon, J. Branco, M.L. Brandi, O. Bruyeère, R. Chapurlat, C. Cooper, B. Cortet, A. Diez-Perez, S. Ferrari, A. Gasparik, M. Herrmann, N. Rye Jorgensen, J. Kanis, J.M. Kaufman, A. Laslop, M. Locquet, R. Matijevic, E. McCloskey, S. Minisola, R. Pikner, J.Y. Reginster, R. Rizzoli, P. Szulc, M. Vlaskovska, E. Cavalier |
|
Alternative and complementary therapies in osteoarthritis and cartilage repair | N.R. Fuggle, C. Cooper, R.O.C. Oreffo, A.J. Price, J.F. Kaux, E. Maheu, M. Cutolo, G. Honvo, P. G. Conaghan, F. Berenbaum, J. Branco, M.L. Brandi, B. Cortet, N. Veronese, A.A. Kurth, R. Matijevic, R. Roth, J.P. Pelletier, J. Martel‑Pelletier, M. Vlaskovska, T. Thomas, W.F. Lems, N. Al‑Daghri, O. Bruyère, R. Rizzoli, J.A. Kanis, J.Y. Reginster |
|
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society of Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) | O. Bruyère, G. Honvo, N. Veronese, N.L. Arden, J. Branco, E. M. Curtis, N.M. Al-Daghri, G. Herrero-Beaumont, J. Martel-Pelletier, J.P. Pelletier, F. Rannou, R. Rizzoli, R. Roth, D. Uedelhart, C. Cooper, J.Y. Reginster |
|
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture | M. Hiligsmanna, S. A. Williams, L.A. Fitzpatrick, S.S. Silverman, R. Weiss, J.Y. Reginster |
|
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) | M. Hiligsmann, D. Cornelissen, B. Vrijens, B. Abrahamsen, N. Al-Daghri, E. Biver, M.L. Brandi, O. Bruyère, N. Burlet, C. Cooper, B. Cortet, E. Dennison, A. Diez-Perez, A. Gasparik, A. Grosso, P. Hadji, P. Halbout, J.A. Kanis, J.M. Kaufman, A. Laslop, S. Maggi, R. Rizzoli, T. Thomas, S. Tuzun, M. Vlaskovska, J.Y. Reginster |
|
East meets West: current practices and policies in the management of musculoskeletal aging | W. Xia, C. Cooper, M. Li, L. Xu, R. Rizzoli, M. Zhu, H. Lin, J. Beard, Y. Ding, W. Yu, E. Cavalier, Z. Zhang, J.A. Kanis, Q. Cheng, Q. Wang, J.Y. Reginster |
|
Equation models developed with bioelectric impedance analysis tools to assess muscle mass: A systematic review | C. Beaudart, O. Bruyere, A. Geerinck, M. Hajaoui, A. Scafoglieri, S. Perkisas, I. Bautmans, E. Gielen, J.Y. Reginster, F. Buckinx, On behalf of the Belgian Aging Muscle Society (BAMS) |
|
Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (SarQoL) questionnaire: An analysis of subjects from 9 validation studies | A. Geerinck, V. Alekna, C. Beaudart, I. Bautmans, C. Cooper, F. De Souza Orlandi, J. Konstantynowicz, B. MonteroErrasquìn, E. Topinkova, M. Tsekoura, J.Y. Reginster, O. Bruyère |
|
Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) | E. Biver, F. Berenbaum, A.M. Valdes, I. Araujo de Carvalho, L.B. Bindels, M.L. Brandi, P.C. Calder, V. Castronovo, E. Cavalier, A. Cherubini, C. Cooper, E. Dennison, C. Franceschi, N. Fuggle, A. Laslop, P. Miossec, T. Thomas, S. Tuzun, N. Veronese, M. Vlaskovska, J.Y. Reginster, R. Rizzoli |
|
Impact of whole dairy matrix on musculoskeletal health and aging-current knowledge and research gaps | N.R.W. Geiker, C. Mølgaard, S. Iuliano, R. Rizzoli, Y. Manios, L.J.C. van Loon, J.M. Lecerf, G. Moschonis, J.Y. Reginster, I. Givens, A. Astrup |
|
Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta‑Analyses and Recommendations for Reporting of Harms | J.Y. Reginster, O. Bruyère, P. G. Conaghan, T. McAlindon, C. Cooper |
|
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review | J.M. Bauer, A.J. Cruz‑Jentoft, R.A. Fielding, J.A. Kanis, J.Y. Reginster, O. Bruyère, M. Cesari, R. Chapurlat, N. Al‑Daghri, E. Dennison, J.M. Kaufman, F. Landi, A. Laslop, M. Locquet, S. Maggi, E. McCloskey, S. Perna, R. Rizzoli, Y. Rolland, M. Rondanelli, P. Szulc, B. Vellas, M. Vlaskovska, C. Cooper |
|
Malnutrition as a Strong Predictor of the Onset of Sarcopenia | C. Beaudart, D. Sanchez-Rodriguez, M. Locquet, J.Y. Reginster, L. Lengelé, O. Bruyère |
|
Outcome Priorities for Older Persons With Sarcopenia | M. Hiligsmann, C. Beaudart, O. Bruyère, E. Biver, J. Bauer, A.J. Cruz-Jentoft, A. Gesmundo, S. Goisser, F. Landi, M. Locquet, S. Maggi, R. Rizzoli, Y. Rolland, N. Vaquero, C. Cooper, J.Y. Reginster, on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) |
|
Physical frailty ICFSR international clinical practice guidelines for identification and management | E. Dent, J.E. Morley, A.J. Cruz-Jentoft, L. Woodhouse, L. Rodríguez-Mañas, L.P. Fried, J. Woo, I. Aprahamian, A. Sanford, J. Lundy, F. Landi, J. Beilby, F.C. Martin, J.m. Bauer, L. Ferrucci, R.A. Merchant, B. Dong, H. Arai, E.O. Hoogendijk, C.W. Won, A. Abbatecola, T. Cederholm, T. Strandberg, L.M. Gutiérrez Robledo, L. Flicker, S. Bhasin, M. Aubertin-Leheudre, H.A. Bischoff-Ferrari, J.M. Guralnik, J. Muscedere, M. Pahor, J. Ruiz, A.M. Negm, J.Y. Reginster, D.L. Waters, B. Vellas |
|
Physical performance trajectories and mortality among nursing home residents: results of the SENIOR cohort | A. Charles, J. Detilleux, F. Buckinx, J.Y. Reginster, B. Gruslin, O. Bruyère |
|
Prediction of Adverse Outcomes in Nursing Home Residents According to Intrinsic Capacity Proposed by the World Health Organization | A. Charles, F. Buckinx, M. Locquet, J.Y. Reginster, J. Petermans, B. Gruslin, O. Bruyère |
|
Radiofrequency echographic multi‑spectrometry for the in‑vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) | A. Diez‑Perez, M.L. Brandi, N. Al‑Daghri, J.C. Branco, O. Bruyère, L. Cavalli, C. Cooper, B. Cortet, B. Dawson‑Hughes, H.P. Dimai, S. Gonnelli, P. Hadji, P. Halbout, J.M. Kaufman, A. Kurth, M. Locquet, S. Maggi, R. Matijevic, J.Y. Reginster, R. Rizzoli, T. Thomas |
|
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) | G. Honvo, R.R. Bannuru, O. Bruyère, F. Rannou, G. Herrero‑Beaumont, D. Uebelhart, C. Cooper, N. Arden, P.G. Conaghan, J.Y. Reginster, T. Thomas, T. McAlindon |
|
Relationship between the changes over time of bone mass and muscle health in children and adults: a systematic review and meta-analysis | M. Locquet, C. Beaudart, N. Durieux, J.Y. Reginster, O. Bruyère |
|
Safety of Cyclooxygenase‑2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | E. Curtis, N. Fuggle, S. Shaw, L. Spooner, G. Ntani, C. Parsons, N. Corp, G. Honvo, J. Baird, S. Maggi, E. Dennison, O. Bruyère,J.Y. Reginster, C. Cooper |
|
Safety of Intra‑articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | G. Honvo, J.Y. Reginster, F. Rannou, X. Rygaert, A. Geerinck, V. Rabenda, T. McAlindon, A. Charles, N. Fuggle, C. Cooper, E. Curtis, N. Arden, B. Avouac, O. Bruyère |
|
Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | N. Fuggle, E. Curtis, S. Shaw, L. Spooner, O. Bruyère, G. Ntani, C. Parsons, P.G. Conaghan, N. Corp, G. Honvo, D. Uebelhart, J. Baird, E. Dennison, J.Y. Reginster, C. Cooper |
|
Safety of Oral Non‑Selective Non‑Steroidal Anti‑Infammatory Drugs in Osteoarthritis: What Does the Literature Say? | C. Cooper, R. Chapurlat, N. Al‑Daghri, G. Herrero‑Beaumont, O. Bruyère, F. Rannou, R. Roth, D. Uebelhart, J.Y. Reginster |
|
Safety of Symptomatic Slow‑Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | G. Honvo, J.Y. Reginster, V. Rabenda, A. Geerinck, O. Mkinsi, A. Charles, R. Rizzoli, C. Cooper, B. Avouac, O. Bruyère |
|
Safety of Topical Non‑steroidal Anti‑Infammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | G. Honvo, V. Leclercq, A. Geerinck, T. Thomas, N. Veronese, A. Charles, V. Rabenda, C. Beaudart, C. Cooper, J.Y. Reginster, O. Bruyère |
|
Total joint replacement improves pain, functional quality of life, and health utilities in patients with late-stage knee and hip osteoarthritis for up to 5 years | A. Neuprez, A.H. Neuprez, J.F. Kaux, W. Kurth, C. Daniel, T. Thirion, J.P. Huskin, P. Gillet, O. Bruyère, J.Y. Reginster |
|
A decade of FRAX: how has it changed the management of osteoporosis? | J. A. Kanis, N. C. Harvey, H. Johansson, E. Liu, L. Vandenput, M. Lorentzon, W.D. Leslie, E. V. McCloskey |
|
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures | J. A. Kanis, N. C. Harvey, E. McCloskey, O. Bruyère, N. Veronese, M. Lorentzon, C. Cooper, R. Rizzoli, G. Adib, N. Al-Daghri, C. Campusano, M. Chandran, B. Dawson-Hughes, K. Javaid, F. Jiwa, H. Johansson, J. K. Lee, E. Liu, D. Messina, O. Mkinsi, D. Pinto, D. Prieto-Alhambra, K. Saag, W. Xia, L. Zakraoui, J. -Y. Reginster |
|
Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial | J. M. Bauer, S. Verlaan, I. Bautmans, K. Brandt, L. M. Donini, M. Maggio, M. E.T. McMurdo, T. Mets, C. Seal, S. L. Wijers, G. P. Ceda, G. De Vito, G. Donders, M. Drey, C. Greig, U. Holmbäck, M. Narici, J. McPhee, E. Poggiogalle, D. Power, A. Scafoglieri, R. Schultz, C. C. Sieber, T. Cederholm |
|
Nutrition, frailty, and sarcopenia | A. J. Cruz‑Jentoft, E. Kiesswetter, M. Drey, C. C. Sieber |
|
Sarcopenia: revised European consensus on definition and diagnosis | A. J. Cruz-Jentoft, G. Bahat, J Bauer, Y Boirie, O Bruyère, T Cederholm, C Cooper, F Landi, Y Rolland, A. A. Sayer, S. M. Schneider, C. C. Sieber, E. Topinkova, M. Vandewoude, M. Visser, M. Zamboni |
|
1+1+1 = Multimorbidität ist mehr als die Addition von Monopathologien (1+1+1 = Multimorbidity is More than the Addition of Monopathologies) | C. C. Sieber |
|
ESPEN guideline on clinical nutrition and hydration in geriatrics | D. Volkert, A. M. Beck, T. Cederholm, A. Cruz-Jentoft, S. Goisser, L. Hooper, E. Kiesswetter, M. Maggio, A. Raynaud-Simon, C. C. Sieber, L. Sobotka, D. van Asselt, R. Wirth, S. C. Bischoff |
|
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis | M. Lorentzon, J. Branco, M. L. Brandi, O. Bruyère, R. Chapurlat, C. Cooper C, B. Cortet, A. Diez-Perez, S. Ferrari, A. Gasparik, M. Herrmann, N. Rye Jorgensen, J. A. Kanis, J.-M. Kaufman, A. Laslop, M. Locquet, R. Matijevic, E. McCloskey, R. Pikner, S. Minisola, J.-Y. Reginster, R. Rizzoli, P. Szulc, M. Vlaskovska, E. Cavalier |
|
Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) | E. Biver, F. Berenbaum, A. M. Valdes, I. Araujo de Carvalho, L. B. Bindels, M. L. Brandi, P. C. Calder, V. Castronovo, E. Cavalier, A. Cherubini, C. Cooper, E. Dennison, C. Franceschi, N. Fuggle, A. Laslop, P. Miossec, T. Thomas, S. Tuzun, N. Veronese, M. Vlaskovska, J.-Y. Reginster, R. Rizzoli |
|
Radiofrequency echographic multi‑spectrometry for the in‑vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) | A. Diez‑Perez, M. L. Brandi, N. Al‑Daghri, J. C. Branco, O. Bruyère, L. Cavalli, C. Cooper, B. Cortet, B. Dawson‑Hughes, H. P. Dimai, S. Gonnelli, P. Hadji, P. Halbout, J.-M. Kaufman, A. Kurth, M. Locquet, S. Maggi, R. Matijevic, J.-Y. Reginster, R. Rizzoli, T. Thierry |
|
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) | M. Hiligsmann, D. Cornelissen, B. Vrijens, B. Abrahamsen, N. Al-Daghri, E. Biver, M. L. Brandi, O. Bruyère, N. Burlet, C. Cooper, B. Cortet, E. Dennison, A. Diez-Perez, A. Gasparik, A. Grosso, P. Hadji, P. Halbout, J. A. Kanis, J.-M. Kaufman, A. Laslop, S. Maggi, R. Rizzoli, T. Thomas, S. Tuzun, M. Vlaskovska, J.-Y. Reginster |
|
East meets West: current practices and policies in the management of musculoskeletal aging | W. Xia, C. Cooper, M. Li, L. Xu, R. Rizzoli, M. Zhu, H. Lin, J. Beard, Y. Ding, W. Yu, E. Cavalier, Z. Zhang, J. A. Kanis, Q. Cheng, Q. Wang, J.-Y. Reginster |
|
Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta‑Analyses and Recommendations for Reporting of Harms | Reginster JY, Bruyère B, Conaghan P G., McAlindon T, Cooper C |
|
Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) | de Wit M, Cooper C, Tugwell P, Bere N, Kirwan J, Conaghan P G., Roberts C, Aujoulat I, Al‑Daghri N, Araujo de Carvalho13 I, Barker M, Bedlington N, Brandi ML, Bruyère O, Burlet N, Halbout P, Hiligsmann M, Jiwa F, Kanis J A., Laslop A, Lawrence W, Pinto D, Prieto Yerro C, Rabenda V, Rizzoli R, Scholte‑Voshaar M, Vlaskovska M, Reginster JY |
|
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review | Bauer J M., Cruz‑Jentoft A J., Fielding RA, Kanis J A., Reginster JY, Bruyère O, Cesari M, Chapurlat R, Al‑Daghri N, Dennison E, Kaufman JM, Landi F, Laslop A, Locquet M, Maggi S, McCloskey E, Perna S, Rizzoli R, Rolland Y, Rondanelli M, Szulc P, Vellas B, Vlaskovska M, Cooper C, FMedSci |
|
Practical guidance for patient-centred health research | de Wit M, Cooper C, Reginster JY, on behalf of the WHO-ESCEO Working Group |
|
Safety of Topical Non‑steroidal Anti‑Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | Honvo G, Leclercq V, Geerinck A, Thomas T, Veronese N, Charles A, Rabenda V, Beaudart C, Cooper C, Reginster JY, Bruyère O |
|
Safety of Symptomatic Slow‑Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | Honvo G, Reginster JY, Rabenda V, Geerinck A, Mkinsi O, Charles A, Rizzoli R, Cooper C, Avouac B, Bruyère O |
|
Safety of Intra‑articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | Honvo G, Reginster JY, Rannou F, Rygaert X, Geerinck A, Rabenda V, McAlindon T, Charles A, Fuggle N, Cooper C, Curtis E, Arden N, Avouac B, Bruyère O |
|
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) | Honvo G, Bannuru R R., Bruyère O, Rannou F, Herrero‑Beaumont G, Uebelhart D, Cooper C, Arden N, Conaghan P. G., Reginster JY |
|
Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | Fuggle N, Curtis E, Shaw S, Spooner L, Bruyère O, Ntani G, Parsons C, Conaghan P. C, Corp N, Honvo G, Uebelhart D, Baird J, Dennison E, Reginster JY, Cooper C |
|
Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women | Kanis J. A. , Cooper C, Reginster JY |
|
Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis | Kucharz E. J., Szántó S, Goycheva MI, Petronijević M, Šimnovec K, Domżalski M, Gallelli L, Kamenov Z, Konstantynowicz J, Radunović G, Šteňo B, Stoilov R, Stok R, Vrana R, Bruyère O, Cooper C, Reginster JY |
|
Safety of Cyclooxygenase‑2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta‑Analysis | Curtis E, Fuggle N, Shaw S, Spooner L, Ntani G, Parsons C, Corp N, Honvo G, Baird J, Maggi S, Dennison E, Bruyère O, Reginster JY, Cooper C |
|
Safety of Oral Non‑Selective Non‑Steroidal Anti‑Inflammatory Drugs in Osteoarthritis: What Does the Literature Say? | Cooper C, Chapurlat R, Avouac B, Al‑Daghri N, Herrero‑Beaumont G, Bruyère O, Rannou F, Roth R, Uebelhart D, Reginster JY |
|
Safety of Paracetamol in Osteoarthritis: What Does the Literature Say? | Conaghan PG, Arden N, Avouac B, Migliore A, Rizzoli R |
|
Assessment of Muscle Function and Physical Performance in Daily Clinical Practice | Beaudart C, Rolland Y, Cruz‑Jentoft AJ, Bauer JM, Sieber C, Cooper C, Al‑Daghri Nasser, Araujo de Carvalho I, Bautmans I, Bernabei R, Bruyère O, Cesari M, Cherubini A, Dawson‑Hughes B, Kanis JA, Kaufman JM, Landi F, Maggi S, McCloskey E, Petermans J, Rodriguez Maña L, Reginster JY, Roller‑Wirnsberger R, Schaap LA, Uebelhart D, Rizzoli R, Fielding RA |
|
An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) | Bruyère O, Honvo G, Veronese N, Arden NK, Branco J, Curtise EM, Al-Daghri NM, Herrero-Beaumont G, Martel-Pelletier J, Pelletier JP, Rannou F, Rizzoli R, Roth R, Uebelhart D, Cooper C, Reginster JY |
|
Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation | Hiligsmann M, Reginster JY, Tosteson A.N.A, Bukata S.V, Saag K.G, Gold D.T, Halbout P, Jiwa F, Lewiecki E.M, Pinto D, Adachi J.D, Al-Daghri N, Bruyère O, Chandran M, Cooper C, Harvey N.C, Einhorn T.A, Kanis J.A, Kendler D.L, Messina O.D, Rizzoli R, Si L, Silverman S |
|
The structure and predictive value of intrinsic capacity in a longitudinal study of ageing | John R Beard, A T Jotheeswaran, Matteo Cesari, Islene Araujo de Carvalho |
|
Sarcopenia: revised European consensus on definition and diagnosis | Alfonso J. Cruz-Jentoft, Gülistan Bahat, Jürgen bauer, Yves Boirie, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, Stéphane M. Schneider, Cornel C. Sieber, Eva Topinkova, Maurits Vandewoude, Marjolein Visser, Mauro Zamboni |
|
Physical frailty: ICFSR International Clinical Practice Guidelines for Identification and Management | E. Dent, J.E. Morley, A.J. Cruz-Jentoft, L. Woodhouse, L. Rodríguez-Mañas, L.P. Fried, J. Woo, I. Aprahamian, A. Sanford, J. Lundy, F. Landi, J. Beilby, F.C. Martin, J.M. Bauer, L. Ferrucci, R.A. Merchant, B. Dong, H. Arai, E.O. Hoogendijk, C.W. Won, A. Abbatecola, T. Cederholm, T. Strandberg, L.M. Gutiérrez Robledo, L. Flicker, S. Bhasin, M. Aubertin-Leheudre, H.A. Bischoff-Ferrari, J.M. Guralnik, J. Muscedere, M. Pahor, J. Ruiz, A.M. Negm, J.Y. Reginster, D.L. Waters, B. Vellas |
|
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review | Jürgen M. Bauer, Alfonso J. Cruz‑Jentoft, Roger A. Fielding, John A. Kanis, Jean‑Yves Reginster, Olivier Bruyère, Matteo Cesari, Roland Chapurlat, Nasser Al‑Daghri, Elaine Dennison, Jean‑Marc Kaufman, Francesco Landi, Andrea Laslop, Médéa Locquet, Stefania Maggi, Eugene McCloskey, Simone Perna, René Rizzoli, Yves Rolland, Mariangela Rondanelli, Pawel Szulc, Bruno Vellas, Mila Vlaskovska, Cyrus Cooper FMedSci |
|
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition | Nicolaas E.P. Deutz, Ione Ashurst, Maria D. Ballesteros, Danielle E. Bear, Alfonso J. Cruz-Jentoft, Laurence Genton, Francesco Landi, Alessandro Laviano, Kristina Norman, Carla M. Prado |
|
Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial | S. Sabico, A. Al-Mashharawi, N. M. Al-Daghri, K. Wani, O. E. Amer, D. S. Hussain, M. G. A. Ansari, M. S. Masoud, M. S. Alokail, P. G. McTernan |
|
Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia | C. Beaudart, J.-Y. Reginster, A. Geerinck, M. Locquet & O. Bruyère |
|
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting | J. A. Kanis, C. Cooper, R. Rizzoli, B. Abrahamsen, N. M. Al-Daghri, M. L. Brandi, J. Cannata-Andia, B. Cortet, H. P. Dimai, S. Ferrari, P. Hadji, N. C. Harvey, M. Kraenzlin, A. Kurth, E. McCloskey, S. Minisola, T. Thomas, J.-Y. Reginster, for the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) |
|
Pharmacological interventions in frailty and sarcopenia: report by the international conference on frailty and sarcopenia research task force | M. Cesari, R. Fielding, O. Bénichou, R. Bernabei, S. Bhasin, J.M. Guralnik, A. Jette, F. Landi, M. Pahor, L. Rodriguez-Manas, Y. Rolland, R. Roubenoff, A.J. Sinclair, S. Studenski, T. Travison, B. Vellas on behalf of the international conference on frailty and sarcopenia research task force |
|
Sarcopenia trials in specific diseases: report by the international conference on frailty and sarcopenia research task force | B. Vellas, R. Fielding, S. Bhasin, F. Cerreta, B. Goodpaster, J.M. Guralnik, S. Kritchevsky, V. Legrand, C. Forkin, J. Magaziner, J.E. Morley, L. Rodriguez-Manas, R. Roubenoff, S. Studenski, D.T. Villareal, M. Cesari, on behalf of the international conference on frailty and sarcopenia research task force |
|
Occupation-dependent loading increases bone strength in men | E. Biver, G. Perréard Lopreno, M. Hars, B. van Rietbergen, J. P. Vallée, S. Ferrari, M. Besse, R. Rizzoli |
|
Clinical usefulness of bone turnover marker concentrations in osteoporosis | H.A. Morris, R. Eastell, N.R. Jorgesen, E. Cavalier, S. Vasikaran, S.A.P. Chubb, J.A. Kanis, C. Cooper, K. Makris, on behalf of the IFCC-IOFWorking Group for Standardisation of Bone Marker Assays (WG-BMA): |
|
Bone markers during acute burn care: Relevance to clinical practice? | Anne-Françoise Rousseau, Pierre Damas, Pierre Delanaye, Etienne Cavalier |
|
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice | Nicolas Bonnet, Maude Gerbaix, Michael Ominsky, Patrick Ammann, Paul J. Kostenuik, Serge L. Ferrari |
|
Romosozumab Treatment in Postmenopausal Women with Osteoporosis | F. Cosman, D.B. Crittenden, J.D. Adachi, N. Binkley, E. Czerwinski, S. Ferrari, L.C. Hofbauer, E. Lau, E.M. Lewiecki, A. Miyauchi, C.A.F. Zerbini, C.E. Milmont, L. Chen, J. Maddox, P.D. Meisner, C. Libanati, and A. Grauer |
|
Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees | Mélany Hars, Emmanuel Biver, Thierry Chevalley, François Herrmann, René Rizzoli, Serge Ferrari, and Andrea Trombetti |
|
Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus | F. S. Hough, D. D. Pierroz, C. Cooper, S. L. Ferrari and The IOF CSA Bone and Diabetes Working Group |
|
Periostin action in bone | Nicolas Bonnet, Patrick Garnero, Serge Ferrari |
|
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club | E. Cavalier, P. Bergmann, O. Bruyère, P. Delanaye, A. Durnez, J.-P. Devogelaer, S. L. Ferrari, E. Gielen, S. Goemaere, J.-M. Kaufman, A. Nzeusseu Toukap, J.-Y. Reginster, A.-F. Rousseau, S. Rozenberg, A. J. Scheen, J.-J. Body |
|
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture | Serge Ferrari, Jean-Yves Reginster, Maria Luisa Brandi, John A. Kanis, Jean-Pierre Devogelaer, Jean-Marc Kaufman, Jean-Marc Féron, Andreas Kurth, René Rizzoli |
|
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis | Bente Langdahl, Serge Ferrari and David W. Dempster |
|
Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal women | Claire Durosier-Izart, Emmanuel Biver, Fanny Merminod, Bert van Rietbergen, Thierry Chevalley, François R Herrmann, Serge L Ferrari, and René Rizzoli |
|
Within- and Across-Sex Inheritance of Bone Microarchitecture | Jessica Pepe, Emmanuel Biver, Nicolas Bonnet, François R. Herrmann, René Rizzoli, Thierry Chevalley, and Serge Livio Ferrari |
|
Cathepsin K Controls Cortical Bone Formation by Degrading Periostin | Nicolas Bonnet, Julia Brun, Jean-Charles Rousseau, Le T. Duong, and Serge L. Ferrari |
|
Evaluation of hip abductor and adductor strength in the elderly: a reliability study | Simone Gafner1, Caroline H. G. Bastiaenen, Philippe Terrier, Ilona Punt, Serge Ferrari, Gabriel Gold, Rob de Bie and Lara Allet |
|
Diabetes and Bone | Serge Ferrari |
|
Mechanisms of diabetes mellitusinduced bone fragility | Nicola Napoli, Manju Chandran, Dominique D. Pierroz, Bo Abrahamsen, Ann V. Schwartz and Serge L. Ferrari |
|
Populations and outcome measures used in ongoing research in sarcopenia | Gloria Gabriela Peña Ordóñez, Lilia Patricia Bustamante Montes, Ninfa Ramírez Duran, Carmen Sánchez Castellano, Alfonso J. Cruz-Jentoft |
|
Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition | Gulistan Bahat, Asli Tufan, Fatih Tufan, Cihan Kilic, Timur Selçuk Akpinar, Murat Kose, Nilgun Erten, Mehmet Akif Karan, Alfonso J. Cruz-Jentoft |
|
Baseline frailty evaluation in drug development | F. Cerreta, J. Ankri, D. Bowen, A. Cherubini, A.J. Cruz Jentoft, A. Guðmundsson, M. Haberkamp, P. Jansen, N. Marchionni, S. Morgan, E. Rönnemaa, M. Petrovic, A. Pilotto, M. Rosa, H. Wildiers |
|
Impacts of High-Protein Oral Nutritional Supplements Among Malnourished Men and Women with Sarcopenia: A Multicenter, Randomized, Double-Blinded, Controlled Trial | Joel T. Cramer PhD , Alfonso J. Cruz-Jentoft MD, PhD, Francesco Landi MD, PhD, Mary Hickson PhD, RD, Mauro Zamboni MD, Suzette L. Pereira PhD, Deborah S. Hustead PhD, Vikkie A. Mustad PhD |
|
Cut-off points for muscle mass — not grip strength or gait speed —determine variations in sarcopenia prevalence | F. Masanés, X. Rojano I Luque, A. Salvà, J.A. Serra-Rexach, I. Artaza, F. Formiga, F. Cuesta, A. López Soto, D. Ruiz, A.J. Cruz-Jentoft |
|
Effectiveness of Non-Pharmacological Interventions to Prevent Falls in Older People: A Systematic Overview. The SENATOR Project ONTOP Series | Joseph M. Rimland, Iosief Abraha, Giuseppina Dell’Aquila, Alfonso Cruz-Jentoft, Roy Soiza, Adalsteinn Gudmusson, Mirko Petrovic, Denis O’Mahony, Chris Todd, Antonio Cherubini |
|
La prevalencia de sarcopenia en residencias de España: comparación de los resultados del estudio multicéntrico ELLI con otras poblaciones | Antoni Salvà, José Antonio Serra-Rexach, Iñaki Artaza, Francesc Formiga, Xavier Rojano i Luque, Federico Cuesta, Alfonso López-Soto, Ferran Masanés, Domingo Ruiz, y Alfonso J. Cruz-Jentoft |
|
Hip fracture, mortality risk, and cause of death over two decades | M. von Friesendorff, F. E. McGuigan, A. Wizert, C. Rogmark, A. H. Holmberg, A. D. Woolf, K. Akesson |
|
The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis | M. Hiligsmann, G. Ronda, T. van der Weijden, A. Boonen |
|
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures | O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster |
|
Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment | H. Penton, M. Hiligsmann, M. Harrison, J.-Y. Reginster, A. Boonen, N. Bansback |
|
Nutrition, frailty, and sarcopenia | Alfonso J. Cruz-Jentoft, Eva Kiesswetter, Michael Drey, Cornel C. Sieber |
|
Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France | M. Hiligsmann, N. Burlet, P. Fardellone, N. Al-Daghri, J.-Y. Reginster |
|
Patients’ preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment | Mickaël Hiligsmann, Benedict G. Dellaert, Carmen D. Dirksen, Verity Watson, Sandrine Bours, Stefan Goemaere, Jean-Yves Reginster, Christian Roux, Bernie McGowan, Carmel Silke, Bryan Whelan, Adolfo Diez-Perez, Elisa Torres, Georgios Papadakis, Rene Rizzoli, Cyrus Cooper, Gill Pearson and Annelies Boonen |
|
Age-Related Variations of Muscle Mass, Strength, and Physical Performance in Community-Dwellers: Results From the Milan EXPO Survey | Francesco Landi MD, PhD, Riccardo Calvani PhD, Matteo Tosato MD, PhD, Anna Maria Martone MD, Domenico Fusco MD, PhD, MD, Alex Sisto BA, Elena Ortolani MD, Giulia Savera BS, Sara Salini MD, Emanuele Marzetti MD, PhD |
|
Sarcopenia: an overview | Emanuele Marzetti, Riccardo Calvani, Matteo Tosato, Matteo Cesari, Mauro Di Bari, Antonio Cherubini, Agnese Collamati, Emanuela D’Angelo, Marco Pahor, Roberto Bernabei, Francesco Landi, on behalf of the SPRINTT Consortium |
|
The “Sarcopenia and Physical fRailty IN older people: multicomponenT Treatment strategies” (SPRINTT) randomized controlled trial: design and methods | Francesco Landi, Matteo Cesari, Riccardo Calvani, Antonio Cherubini, Mauro Di Bari, Raphael Bejuit, Jerome Mshid, Sandrine Andrieu, Alan J. Sinclair, Cornel C. Sieber, Bruno Vellas, Eva Topinkova, Timo Strandberg, Leocadio Rodriguez-Manas, Fabrizia Lattanzio, Marco Pahor, Ronenn Roubenoff, Alfonso J. Cruz-Jentoft, Roberto Bernabei, Emanuele Marzetti, on behalf of the SPRINTT Consortium |
|
Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia | Charlotte Beaudart, Emmanuel Biver, Jean-Yves Reginster, René Rizzoli, Yves Rolland, Ivan Bautmans, Jean Petermans, Sophie Gillain, Fanny Buckinx, Nadia Dardenne & Olivier Bruyère |
|
The eff ect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study | Lee E Bayliss, David Culliford, A Paul Monk, Sion Glyn-Jones, Daniel Prieto-Alhambra, Andrew Judge, Cyrus Cooper, Andrew J Carr, Nigel K Arden, David J Beard, Andrew J Price |
|
English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia | Charlotte Beaudart, Mark Edwards, Charlotte Moss, Jean-Yves Reginster, Rebecca Moon, Camille Parsons, Christophe Demoulin, René Rizzoli, Emmanuel Biver, Elaine Dennison, Olivier Bruyère, Cyrus Cooper |
|
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis | Charlotte Beaudart, Myriam Zaaria, Françoise Pasleau, Jean-Yves Reginster, Olivier Bruyère |
|
Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review | C. Beaudart, A. Dawson, S. C. Shaw, N. C. Harvey, J. A. Kanis, N. Binkley, J. Y. Reginster, R. Chapurlat, D. C. Chan, O. Bruyère, R. Rizzoli, C. Cooper, E. M. Dennison, the IOF-ESCEO Sarcopenia Working Group |
|
Management of Hypoparathyroidism: Present and Future | John P. Bilezikian, Maria Luisa Brandi, Natalie E. Cusano, Michael Mannstadt, Lars Rejnmark, René Rizzoli, Mishaela R. Rubin, Karen K. Winer, Uri A. Liberman, and John T. Potts, Jr |
|
Occupation-dependent loading increases bone strength in men | E. Biver, G. Perréard Lopreno, M. Hars, B. van Rietbergen, J. P. Vallée, S. Ferrari, M. Besse, R. Rizzoli |
|
Bone health in HIV and hepatitis B or C infections | Emmanuel Biver, Alexandra Calmy and René Rizzoli |
|
A comprehensive fracture prevention strategy in older adults the european union geriatric medicine society (eugms) statement | H. Blain, T. Masud, P. Dargent-Molina, F.c. Martin, E. Rosendahl, N. Van Der Velde, J. Bousquet, A. Benetos, C. Cooper, J. A. Kanis, J.y. Reginster, R. Rizzoli, B. Cortet, M. Barbagallo, B. Vellas, S. Maggi, T. Strandberg, For The Eugms Falls And Fracture Interest Group, The International Association Of Gerontology And Geriatrics For The European Region (Iagg-Er), The European Union Of Medical Specialists (Eums)*, The European Society For Clinical And Economic Aspects Of Osteoporosis And Osteoarthritis (Esceo), And The International Osteoporosis Foundation (Iof) |
|
A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis — From evidence-based medicine to the real-life setting | Olivier Bruyère, Cyrus Cooper, Jean-Pierre Pelletier, Emmanuel Maheu, François Rannou, Jaime Branco, Maria Luisa Brandi, John A. Kanis, Roy D. Altman, Marc C. Hochberg, PhDk, Johanne Martel-Pelletier, Jean-Yves Reginster |
|
Sarcopenia in daily practice: assessment and management | Charlotte Beaudart, Eugène McCloskey, Olivier Bruyère, Matteo Cesari, Yves Rolland, René Rizzoli, Islène Araujo de Carvalho, Jotheeswaran Amuthavalli Thiyagarajan, Ivan Bautmans, Marie-Claude Bertière, Maria Luisa Brandi, Nasser M. Al-Daghri, Nansa Burlet, Etienne Cavalier, Francesca Cerreta, Antonio Cherubini, Roger Fielding, Evelien Gielen, Francesco Landi, Jean Petermans, Jean-Yves Reginster, Marjolein Visser, John Kanis and Cyrus Cooper |
|
Prepubertal Impact of Protein Intake and Physical Activity on Weight-Bearing Peak Bone Mass and Strength in Males | Thierry Chevalley, Jean-Philippe Bonjour, Marie-Claude Audet, Fanny Merminod, Bert van Rietbergen, Rene Rizzoli, and Serge Ferrari |
|
Effects of a giant exercising board game intervention on ambulatory physical activity among nursing home residents: a preliminary study | Alexandre Mouton, Nicolas Gillet, Flore Mouton, Dave Van Kann, Olivier Bruyère, Marc Cloes, Fanny Buckinx |
|
Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis | Bernard Cortet, Ankita Modi, Jackson Tang, Chun-Po Steve Fan, Shiva Sajjan and Jessica Papadopoulos Weaver |
|
Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up | M. Belhassen, C. B. Confavreux, B. Cortet, L. Lamezec, M. Ginoux, E. Van Ganse |
|
Region specific Raman spectroscopy analysis of the femoral head reveals that trabecular bone is unlikely to contribute to non-traumatic osteonecrosis | Tristan Pascart, Guillaume Falgayrac, Henri Migaud, Jean-François Quinchon, Laurène Norberciak, Jean-François Budzik, Julien Paccou, Anne Cotten, Guillaume Penel, Bernard Cortet |
|
International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates | A. Diez-Perez, K. E. Naylor, B. Abrahamsen, D. Agnusdei, M. L. Brandi, C. Cooper, E. Dennison, E. F. Eriksen, D. T. Gold, N. Guañabens, P. Hadji, M. Hiligsmann, R. Horne, R. Josse, J. A. Kanis, B. Obermayer-Pietsch, D. Prieto-Alhambra, J.-Y. Reginster, R. Rizzoli, S. Silverman, M. C. Zillikens, R. Eastell, Adherence Working Group of the International Osteoporosis Foundation and the European Calcified Tissue Society |
|
Does low bone mineral density predict mortality? | Bernard Cortet |
|
Energy and nutrient content of food served and consumed by nursing home residents | F. Buckinx, S. Allepaerts, N. Paquot4, J.-Y. Reginster, C. de Cock, J. Petermans, O. Bruyère |
|
Physical activity and osteoarthritis: a consensus study to harmonise self-reporting methods of physical activity across international cohorts | L. S. Gates, K. M. Leyland, S. Sheard, K. Jackson, P. Kelly, L. F. Callahan, R. Pate, E. M. Roos, B. Ainsworth, C. Cooper, C. Foster, J. L. Newton, M. E. Batt, N. K. Arden |
|
BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial | Francis H Glorieux, Jean-Pierre Devogelaer, Michaela Durigova, Stefan Goemaere, Sarah Hemsley, Franz Jakob, Uwe Junker, Jon Ruckle, Lothar Seefried, and Peter J Winkle |
|
FRAX predicts incident falls in elderly men: findings from MrOs Sweden | N. C. Harvey, H. Johansson, A. Odén, M. K. Karlsson, B. E. Rosengren, Ö. Ljunggren, C. Cooper, E. McCloskey, J. A. Kanis, C. Ohlsson, D. Mellström |
|
High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients | Guillaume Jean, Charles Chazot, Eric Bresson, Eric Zaoui, Etienne Cavalier |
|
Impact of physical function impairment and multimorbidity on mortality among community-living older persons with sarcopaenia: results from the ilSIRENTE prospective cohort study | Francesco Landi, Riccardo Calvani, Matteo Tosato, Anna Maria Martone, Roberto Bernabei, Graziano Onder, Emanuele Marzetti |
|
Imminent risk of fracture after fracture | H. Johansson, K. Siggeirsdóttir, N. C. Harvey, A. Odén, V. Gudnason, E. McCloskey, G Sigurdsson, J. A. Kanis |
|
Quality of life, resource use, and costs related to hip fracture in Estonia | M. Jürisson, H. Pisarev, J. Kanis, F. Borgström, A. Svedbom, R. Kallikorm, M. Lember, A. Uusküla |
|
A systematic review of intervention thresholds based on FRAX | John A. Kanis, Nicholas C. Harvey, Cyrus Cooper, Helena Johansson, Anders Odén, Eugene V. McCloskey, The Advisory Board of the National Osteoporosis Guideline Group |
|
Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ | Aliya A. Khan, Archie Morrison, David L. Kendler, Rene Rizzoli, David A. Hanley, Dieter Felsenberg, Laurie K. McCauley, Felice O’Ryan, Ian R. Reid, Salvatore L. Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B. Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M. Cheung, Suzanne N. Morin, Basel Masri, Cyrus Cooper, Sarah L. Morgan, Barbara Obermayer-Pietsch, Bente L. Langdahl, Rana Al Dabagh, K. Shawn Davison, George K. Sándor, Robert G. Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D. Pierroz, Riad Sulimani, Deborah P. Saunders, Jacques P. Brown, Juliet Compston on behalf of the International Task Force on Osteonecrosis of the Jaw |
|
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus | A. A. Khan, D. A. Hanley, R. Rizzoli, J. Bollerslev, J.E.M Young, L. Rejnmark, R. Thakker, P. D’Amour, T. Paul, S. Van Uum, M. Zakaria Shrayyef, D. Goltzman, S. Kaiser, N. E. Cusano, R. Bouillon, L. Mosekilde, A.W. Kung, S. D. Rao, S. K. Bhadada, B. L. Clarke, J. Liu, Q. Duh, E. Michael Lewiecki, F. Bandeira, R. Eastell, C. Marcocci, S. J. Silverberg, R. Udelsman, K. Shawn Davison, J. T. Potts Jr, M. L. Brandi, J. P. Bilezikian |
|
Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX®? in Portugal | Andréa Marques, Óscar Lourenço, Gustaf Ortsäter, Fredrik Borgström, John A. Kanis, José António P. da Silva |
|
Clinical Utility of Using Lumbar Spine Trabecular Bone Score to Adjust Fracture Probability: The Manitoba BMD Cohort | P. Martineau, W.D. Leslie, H. Johansson, A. Oden, E.V. McCloskey, D. Hans, J.A. Kanis |
|
Understanding FRAX and the assessment of fracture risk in primary care in 2016 | E. V. McCloskey, N. C. Harvey, J. A. Kanis |
|
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX | Eugene V McCloskey, Anders Odén, Nicholas C Harvey, William D Leslie, Didier Hans, Helena Johansson, Reinhard Barkmann, Stephanie Boutroy, Jacques Brown, Roland Chapurlat, Petra JM Elders, Yuki Fujita, Claus-C Glüer, David Goltzman, Masayuki Iki, Magnus Karlsson, Andreas Kindmark, Mark Kotowicz, Norio Kurumatani, Timothy Kwok, Oliver Lamy, Jason Leung, Kurt Lippuner,16 Östen Ljunggren, Mattias Lorentzon, Dan Mellström, Thomas Merlijn, Ling Oei, Claes Ohlsson, Julie A Pasco, Fernando Rivadeneira, Björn Rosengren, Elisabeth Sornay-Rendu, Pawel Szulc, Junko Tamaki, and John A Kanis |
|
Osteoporosis: Is milk a kindness or a curse? | Patrice Fardellonea, Alice Séjournéa, Hubert Blainc, Bernard Cortetd, Thierry Thomase, and GRIO Scientific Committee |
|
Clinical usefulness of bone turnover marker concentrations in osteoporosis | Howard A Morris, Howard Morris, Richard Eastell, Niklas R Jorgensen, Etienne Cavalier, Samuel Vasikaran, S A Chubb, John A Kanis, Cyrus Cooper, Konstantinos Makris |
|
Measures of hip morphology are related to development of worsening radiographic hip osteoarthritis over 6 to 13 year follow-up: the Johnston County Osteoarthritis Project | A.E. Nelson, J.L. Stiller, X.A. Shi, K.M. Leyland, J.B. Renner, T.A. Schwartz, N.K. Arden, J.M. Jordan |
|
How the reference values for serum parathyroid hormone concentration are (or should be) established? | J.-C. Souberbielle, F. Brazier, M.-L. Piketty, C. Cormier, S. Minisola, E. Cavalier |
|
A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D3 Serum Level after Vitamin D3 Supplementation | Etienne Cavalier, Bernard Jandrain, Monte Coffiner, Stéphanie Da Silva, Sophie De Niet, Francis Vanderbist and Jean-Claude Souberbielle |
|
The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids | M. van Middelkoop, N.K. Arden, I. Atchia, F. Birrell, J. Chao, M.U. Rezende, R.G.W. Lambert, P. Ravaud, J.W. Bijlsma, M. Doherty, K.S. Dziedzic, L.S. Lohmander, T.E. McAlindon, W. Zhang, S.M.A. Bierma-Zeinstra |
|
Low-trauma fractures without osteoporosis | E. Lespessailles, B. Cortet, E. Legrand, P. Guggenbuhl, C. Roux |
|
Relationship between frailty, physical performance and quality of life among nursing home residents: the SENIOR cohort | F. Buckinx, J. Y. Reginster, J. Petermans, J. L. Croisier, C. Beaudart, T. Brunois, O. Bruyère |
|
Protein Intake and Muscle Health in Old Age: From Biological Plausibility to Clinical Evidence | Francesco Landi, Riccardo Calvani, Matteo Tosato, Anna Maria Martone, Elena Ortolani, Giulia Savera, Emanuela D’Angelo, Alex Sisto and Emanuele Marzetti |
|
Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect | Cécile Olejnik, Guillaume Falgayrac, Alexandrine During, Bernard Cortet, Guillaume Penel |
|
Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis | Carlen Reyes, Kirsten M. Leyland, George Peat, Cyrus Cooper, Nigel K. Arden, and Daniel Prieto-Alhambra |
|
Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study | Joanna C. Robson, Amit Kiran, Joe Maskell, Andrew Hutchings, Nigel Arden, Bhaskar Dasgupta, William Hamilton, Akan Emin, David Culliford, and Raashid Luqmani |
|
Sarcopenia in heart failure: mechanisms and therapeutic strategies | Agnese Collamati, Emanuele Marzetti, Riccardo Calvani, Matteo Tosato, Emanuela D’Angelo, Alex N Sisto, Francesco Landi |
|
Are there three main subgroups within the patellofemoral pain population? A detailed characterisation study of 127 patients to help develop targeted intervention (TIPPs) | James Selfe, Jessie Janssen, Michael Callaghan, Erik Witvrouw, Chris Sutton, Jim Richards, Maria Stokes, Denis Martin, John Dixon, Russell Hogarth, Vasilios Baltzopoulos, Elizabeth Ritchie, Nigel Arden, Paola Dey |
|
Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients | Jean-Claude Souberbielle, Catherine Massart, Sylvie Brailly-Tabard, Catherine Cormier, Etienne Cavalier, Pierre Delanaye and Philippe Chanson |
|
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO | Karel Pavelka,Olivier Bruyère,Cyrus Cooper,John A. Kanis, Burkhard F. Leeb, Emmanuel Maheu, Johanne Martel-Pelletier, Jordi Monfort, Jean-Pierre Pelletier, René Rizzoli, Jean-Yves Reginster |
|
Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis | Andrea Levitova, Hana Hulejova, Maja Spiritovic, Karel Pavelka, Ladislav Senolt, Marketa Husakova |
|
The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis – a cohort study | Jakub Závada, Petra Hánová, Jana Hur?áková, Lenka Szczuková, Michal Uher, Šárka Forejtová, Martin Klein, Herman Mann, Marta Olejárová, Olga R?ži?ková, Olga Šléglová, Karel Hejduk, Karel Pavelka |
|
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration | Katerina Chatzidionysiou, Elisabeth Lie, Galina Lukina, Merete L. Hetland, Ellen-Margrethe Hauge, Karel Pavelka, Cem Gabay, Almut Scherer, Dan Nordström, Helena Canhao, Maria José Santos, Matija Tomsic, Ziga Rotar, M. Victoria Hernández, Juan Gomez-Reino, Ioan Ancuta, Tore K. Kvien and Ronald van Vollenhoven |
|
The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in-hospital rehabilitation | F. Landi, R. Calvani, E. Ortolani, S. Salini, A. M. Martone, L. Santoro, A. Santoliquido, A. Sisto, A. Picca, E. Marzetti |
|
Intra articular hyaluronic acid in the management of knee osteoarthritis: Pharmaco-economic study from the perspective of the national health insurance system | Thierry Thomas, Françoise Amouroux, Patrice Vincent |
|
Influence of a fermented protein-fortified dairy product on serum insulin-like growth factor-I in women with anorexia nervosa: A randomized controlled trial | Andrea Trombetti, Edouard Carrier, Alain Perroud, François Lang, François R. Herrmann, René Rizzoli |
|
Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms | A. Trombetti, E. R. Christ, C. Henzen, G. Gold, M. Brändle, F. R. Herrmann, C. Torriani, F. Triponez, M. Kraenzlin, R. Rizzoli, C. Meier |
|
Relationship between ambulatory physical activity assessed by activity trackers and physical frailty among nursing home residents | F. Buckinx, A. Moutonc, J.Y. Reginster, J.L. Croisier, N Dardenne, C. Beaudart, J. Nelis, E. Lambert, G. Appelboomd, O. Bruyère |
|
Replication of Associations of Genetic Loci Outside the HLA Region With Susceptibility to Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis | Sebastien Viatte, Jonathan Massey, John Bowes, Kate Duffus, arcOGEN Consortium, Stephen Eyre, Anne Barton, and Jane Worthington |
|
The role of calcium supplementation in healthy musculoskeletal ageing | N. C. Harvey, E. Biver, J.-M. Kaufman, J. Bauer, J. Branco, M. L. Brandi, O. Bruyère, V. Coxam, A. Cruz-Jentoft, E. Czerwinski, H. Dimai, P. Fardellone, F. Landi, J.-Y. Reginster, B. Dawson-Hughes, J. A. Kanis, R. Rizzoli, C. Cooper |
|
Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review | C. Beaudart, A. Dawson, S. C. Shaw, N. C. Harvey, J. A. Kanis, N. Binkley, J. Y. Reginster, R. Chapurlat, D. C. Chan, O. Bruyère, R. Rizzoli, C. Cooper, E. M. Dennison, the IOF-ESCEO Sarcopenia Working Group |
|
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG | Peyman Hadjia, Matti S. Aaprob, Jean-Jacques Body, Michael Gnant, Maria Luisa Brandi, Jean Yves Reginster, M. Carola Zillikens, Claus-C. Glüer, Tobie de Villiers, Rod Baber, G. David Roodman, Cyrus Cooper, Bente Langdahl, Santiago Palacios, John Kanis, Nasser Al-Daghri, Xavier Nogues, Erik Fink Eriksen, Andreas Kurth, Rene Rizzoli, Robert E. Colemanu |
| |
Romosozumab Treatment in Postmenopausal Women with Osteoporosis | F. Cosman, D. B. Crittenden, J. D. Adachi, N. Binkley, E. Czerwinski, S. Ferrari, L. C. Hofbauer, E. Lau, E. M. Lewiecki, A. Miyauchi, C. A. F. Zerbini, C. E. Milmont, L. Chen, J. Maddox, P. D. Meisner, C. Libanati, A. Grauer |
| |
Possibilities for Implementing Fracture Liaison Service in Poland in the Light of a Visit to Glasgow Western Infirmary | J. Amarowicz, E. Czerwiński |
| |
Relationship between total hip (TH) BMD T-score and incidence of nonvertebral fracture (NVFX) with up to 10 years of Denosumab (Dmab) treatment | S. Ferrari, S. Adami, J. P. Brown, F. Cosman, E. Czerwiński, L. H. de Gregório, J. Malouf, J.-Y. Reginster, N. S. Daizadeh, A. Wang, R. B. Wagman, E. M. Lewiecki |
| |
Cost-effectiveness Analysis of Treatment of Osteoporotic Fractures in Relation to FRAX Algorithm in a Sample of Polish Population | J. Amarowicz, D. Bolisęga, J. Rutkowski, A. Kumorek, E. Czerwiński |
| |
Relationship Between Total Hip BMD T-Score and Incidence of Nonvertebral Fracture with up to 8 Years of Denosumab Treatment | S. Ferrari, C. Libanati, C. J. F. Lin, S. Adami, J. P. Brown, F. Cosman, E. Czerwinski, L. H. de Gregório, J. Malouf, J.-Y. Reginster, N. S. Daizadeh, A. Wang, R. B. Wagman, E. M. Lewiecki |
| |
A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial | B. L. Langdahl, C. S. Teglbjærg, P.-R. Ho, R. Chapurlat, E. Czerwinski, D. L. Kendler, J.-Y. Reginster, A. Kivitz, E. M. Lewiecki, P. D. Miller, M. A. Bolognese, M. R. McClung, H. G. Bone, Ö. Ljunggren, B. Abrahamsen, U. Gruntmanis, Y.-C. Yang, R. B. Wagman, F. Mirza, S. Siddhanti, E. Orwoll |
| |
Accumulation of risk factors associated with poor bone health in older adults | J. Zhang, K. Jameson, A. A. Sayer, S. Robinson, C. Cooper, E. Dennison |
| |
Drug utilization in patients with OA: a population-based study | N. Wilson, L. Sanchez-Riera, R. Morros, A. Diez-Perez, M. K. Javaid, C. Cooper, N. K. Arden, D. Prieto-Alhambra |
| |
Individuals With Type 2 Diabetes Mellitus Are at an Increased Risk of Gout But This Is Not Due to Diabetes | J. M. A. Wijnands, C. M. P. G. van Durme, J. H. M. Driessen, A. Boonen, C. Klop, B. Leufkens, C. Cooper, C. D. A. Stehouwer, F. de Vries |
| |
Identification of risk factors for hospital admission using multiple-failure survival models: a toolkit for researchers | L. D. Westbury, H. E. Syddall, S. J. Simmonds, C. Cooper, A. A. Sayer |
| |
Heavy manual work throughout the working lifetime and muscle strength among men at retirement age | K. Walker-Bone, S. D’Angelo, H. E. Syddall, K. T. Palmer, C. Cooper, D. Coggon, A. A. Sayer |
| |
Chronic widespread bodily pain is increased among individuals with history of fracture: findings from UK Biobank | K. Walker-Bone, N. C. Harvey, G. Ntani, T. Tinati, G. T. Jones, B. H. Smith, G. J. Macfarlane, C. Cooper |
| |
Greater access to fast-food outlets is associated with poorer bone health in young children | C. Vogel, C. Parsons, K. Godfrey, S. Robinson, N. C. Harvey, H. Inskip, C. Cooper, J. Baird |
| |
Education and the Relationship Between Supermarket Environment and Diet | C. Vogel, G. Ntani, H. Inskip, M. Barker, S. Cummins, C. Cooper, G. Moon, J. Baird |
| |
Secular trends in fracture incidence in the UK between 1990 and 2012 | R. Y. van der Velde, C. E. Wyers, E. M. Curtis, P. P. M. M. Geusens, J. P. W. van den Bergh, F. de Vries, C. Cooper, T. P. van Staa, N. C. Harvey |
| |
Impact of clinical osteoarthritis of the hip, knee and hand on self- rated health in six European countries: the European Project on OSteoArthritis | N. M. van Schoor, S. Zambon, M. V. Castell, C. Cooper, M. Denkinger, E. M. Dennison, M. H. Edwards, F. Herbolsheimer, S. Maggi, M. Sánchez-Martinez, N. L. Pedersen, R. Peter, L. A. Schaap, J. J. M. Rijnhart, S. van der Pas, D. J. H. Deeg |
| |
Availability and use of neighborhood resources by older people with osteoarthritis: Results from the European Project on OSteoArthritis | S. van der Pas, L. A. Schaap, M. V. Castell, C. Cooper, M. Denkinger, M. H. Edwards, F. Herbolsheimer, S. Maggi, M. Sánchez-Martinez, N. L. Pedersen, R. Peter, S. Zambon, S. B. Wiegersma, J. Dekker, E. M. Dennison, D. J. H. Deeg |
| |
Understanding poor health behaviours as predictors of different types of hospital admission in older people: findings from the Hertfordshire Cohort Study | H. E. Syddall, L. D. Westbury, S. J. Simmonds, S. Robinson, C. Cooper, A. A. Sayer |
| |
Self-reported walking speed: a useful marker of physical performance among community-dwelling older people? | H. E. Syddall, L. D. Westbury, C. Cooper, A. A. Sayer |
| |
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease | J. S. Smolen, S. Collaud Basset, M. Boers, F. Breedveld, C. J Edwards, T. K. Kvien, P. Miossec, T. Sokka-Isler, R. F. van Vollenhoven, E. C. Abadie, O. Bruyère, C. Cooper, H. Mäkinen, T. Thomas, P. Tugwell, J.-Y. Reginster, on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) |
| |
Grip strength among community-dwelling older people predicts hospital admission during the following decade | S. J. SIMMONDS, H. E. SYDDALL, L. D. WESTBURY, R. M. DODDS, C. COOPER, A. A. SAYER |
| |
Bisphosphonate drug holidays: we reap what we sow | S. L. Silverman, J. D. Adachi, E. Dennison, the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group |
| |
International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study | S. Silverman, J. Curtis, K. Saag, J. Flahive, J. Adachi, F. Anderson, R. Chapurlat, C. Cooper, A. Diez-Perez, S. Greenspan, F. Hooven, A. Le Croix, L. March, J. C. Netelenbos, J. Nieves, J. Pfeilschifter, M. Rossini, C. Roux, E. Siris, N. Watts, J. Compston |
| |
Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases | S. Rozenberg, J.-J. Body, O. Bruyère, P. Bergmann, M. L. Brandi, C. Cooper, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, R. Rizzoli, J.-Y. Reginster |
| |
Modifiable early-life risk factors for childhood adiposity and overweight: an analysis of their combined impact and potential for prevention | S. M. Robinson, S. R. Crozier, N. C. Harvey, B. D. Barton, C. M. Law, K. M. Godfrey, C. Cooper, H. M. Inskip |
| |
Can trained volunteers make a difference at mealtimes for older people in hospital? A qualitative study of the views and experience of nurses, patients, relatives and volunteers in the Southampton Mealtime Assistance Study | J. Robison, A. L. Pilgrim, G. Rood, N. Diaper, M. Elia, A. A. Jackson, C. Cooper, A. A. Sayer, S. Robinson, H. C. Roberts |
| |
A review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis population | D. E. Robinson, E. M. Dennison, C. Cooper, T. P. van Staa, W. G. Dixon |
| |
The Association of Grip Strength With Severity and Duration of Parkinson’s: A Cross-Sectional Study | H. C. Roberts, H. E. Syddall, J. W. Butchart, E. L. Stack, C. Cooper, A. A. Sayer |
| |
Limited exposure to ambient ultraviolet radiation and 25-hydroxyvitamin D levels: a systematic review | S. A. Rice, M. Carpenter, A. Fityan, L. M. Vearncombe, M. Ardern-Jones, A. A. Jackson, C. Cooper, J. Baird, E. Healy |
| |
Socio-economic status and the risk of developing hand, hip or knee osteoarthritis: a region-wide ecological study | C. Reyes, M. Garcia-Gil, J. M. Elorza, L. Mendez-Boo, E. Hermosilla, M. K. Javaid, C. Cooper, A. Diez-Perez, N. K. Arden, B. Bolibar, R. Ramos, D. Prieto-Alhambra |
| |
Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion | C. Reyes, A. Pottegård, P. Schwarz, M. K. Javaid, T. P. Van Staa, C. Cooper, A. Diez-Perez, B. Abrahamsen, D. Prieto-Alhambra |
| |
Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis | C. Reyes, K. M. Leyland, G. Peat, C. Cooper, N. K. Arden, D. Prieto-Alhambra |
| |
The position of strontium ranelate in today’s management of osteoporosis | J.-Y. Reginster, M.-L. Brandi, J. Cannata-Andía, C. Cooper, B. Cortet, J.-M. Feron, H. Genant, S. Palacios, J. D. Ringe, R. Rizzoli |
| |
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia | J.-Y. Reginster, C. Cooper, R. Rizzoli, J. A. Kanis, G. Appelboom, I. Bautmans, H. A. Bischoff-Ferrari, M. Boers, M. L. Brandi, O. Bruyère, A. Cherubini, B. Flamion, R. A. Fielding, A. I. Gasparik, L. Van Loon, E. McCloskey, B. H. Mitlak, A. Pilotto, S. Reiter-Niesert, Y. Rolland, Y. Tsouderos, M. Visser, A. J. Cruz-Jentoft |
| |
Optimizing the management of osteoarthritis—Transitioning evidence-based guidelines into practical guidance for real-world clinical practice | J.-Y. Reginster, C. Cooper |
| |
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement | J.-Y. Reginster, S. Reiter-Niesert, O. Bruyère, F. Berenbaum, M.-L. Brandi, J. Branco, J.-P. Devogelaer, G. Herrero-Beaumont, J. Kanis, S. Maggi, E. Maheu, P. Richette, R. Rizzoli, C. Cooper |
| |
Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis | J.-Y. Reginster, C. Cooper, M. Hochberg, J.-P. Pelletier, R. Rizzoli, J. Kanis, E. Abadie, E. Maheu, M. L. Brandi, J.-P. Devogelaer, J. Branco, G. Herrero-Beaumont, P. D’Hooghe, O. Bruyère |
| |
Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11) | V. Rabenda, O. Bruyère, C. Cooper, R. Rizzoli, F. Buckinx, A. Quabron, J.-Y. Reginster |
| |
Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study | D. Prieto-Alhambra, M. K. Javaid, A. Judge, J. Maskell, C. Cooper, N. K. Arden, on behalf of the COASt Study Group |
| |
Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study | D. Prieto-Alhambra, J. Muñoz-Ortego, F. De Vries, D. Vosse, N. K. Arden, P. Bowness, C. Cooper, A. Diez-Perez, P. Vestergaard |
| |
MEASURING APPETITE WITH THE SIMPLIFIED NUTRITIONAL APPETITE QUESTIONNAIRE IDENTIFIES HOSPITALISED OLDER PEOPLE AT RISK OF WORSE HEALTH OUTCOMES | A. L. PILGRIM, D. BAYLIS, K. A. JAMESON, C. COOPER, A. A. SAYER, S. M. ROBINSON, H. C. ROBERTS |
| |
Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys | J.-P. Pelletier, J. Martel-Pelletier, F. Rannou, C. Cooper |
| |
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO | K. Pavelka, O. Bruyère, C. Cooper, J. A. Kanis, B. F. Leeb, E. Maheu, J. Martel-Pelletier, J. Monfort, J.-P. Pelletier, R. Rizzoli, J.-Y. Reginster |
| |
Skeletal muscle morphology in sarcopenia defined using the EWGSOP criteria: findings from the Hertfordshire Sarcopenia Study (HSS) | H. P. Patel, M. C. White, L. Westbury, H. E. Syddall, P. J. Stephens, G. F. Clough, C. Cooper, A. A. Sayer |
| |
How well do radiographic, clinical and self-reported diagnoses of knee osteoarthritis agree? Findings from the Hertfordshire cohort study | C. Parsons, M. Clynes, H. Syddall, D. Jagannath, A. Litwic, S. van der Pas, C. Cooper, E. M. Dennison, M. H. Edwards, the EPOSA research group |
| |
Health and Employment after Fifty (HEAF): a new prospective cohort study | K. T. Palmer, K. Walker-Bone, E. C. Harris, C. Linaker, S. D’Angelo, A. A. Sayer, C. R. Gale, M. Evandrou, T. van Staa, C. Cooper, D. Coggon |
| |
Relationships between bone geometry, volumetric bone mineral density and bone microarchitecture of the distal radius and tibia with alcohol consumption | J. Paccou, M. H. Edwards, K. Ward, K. Jameson, R. Moon, E. Dennison, C. Cooper |
| |
Ischemic heart disease is associated with lower cortical volumetric bone mineral density of distal radius | J. Paccou, M. H. Edwards, K. A. Ward, K. A. Jameson, C. L. Moss, N. C. Harvey, E. M. Dennison, C. Cooper |
| |
Bone Microarchitecture in Men and Women with Diabetes: The Importance of Cortical Porosity | J. Paccou, K. A. Ward, K. A. Jameson, E. M. Dennison, C. Cooper, M. H. Edwards |
| |
Diet quality across early childhood and adiposity at 6 years: the Southampton Women’s Survey | H. Okubo, S. R. Crozier, N. C. Harvey, K. M. Godfrey, H. M. Inskip, C. Cooper, S. M. Robinson, SWS Study Group |
| |
Wellbeing and Arthritis Incidence: the Survey of Health, Ageing and Retirement in Europe | J. A. Okely, C. Cooper, C. R. Gale |
| |
Maternal and early life factors of tooth emergence patterns and number of teeth at one and two years of age | G. Ntani, P. F. Day, J. Baird, K. M. Godfrey, S. M. Robinson, C. Cooper, H. M. Inskip, the Southampton Women’s Survey Study Group |
| |
A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height | T.-L. North, Y. Ben-Shlomo, C. Cooper, I. J. Deary, J. Gallacher, M. Kivimaki, M. Kumari, R. M. Martin, A. Pattie, A. A. Sayer, J. M. Starr, A. Wong, D. Kuh, S. Rodriguez, I. N. M. Day |
| |
Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | J. N. Newton, A. D. M. Briggs, C. J. L. Murray, D. Dicker, K. J. Foreman, H. Wang, M. Naghavi, M. H. Forouzanfar, S. Lockett Ohno, R. M. Barber, T. Vos, J. D. Stanaway, J. C. Schmidt, A. J. Hughes, D. F. J. Fay, R. Ecob, C; Gresser, M. McKee, H. Rutter, I. Abubakar, R. Ali, H. R. Anderson, A. Banerjee, D. A. Bennett, E. Bernabé, K. S. Bhui, S. M. Biryukov, R. R. Bourne, C. E. G. Brayne, N. G. Bruce, T. S. Brugha, M. Burch, S. Capewell, D. Casey, R. Chowdhury, M. M. Coates, C. Cooper, J. A. Critchley, P. I. Dargan, M. K. Dherani, P. Elliott, M. Ezzati, K. A. Fenton, M. S. Fraser, T. Fürst, F. Greaves, M. A. Green, D. J. Gunnell, B. M. Hannigan, R. J. Hay, S. I. Hay, H. Hemingway, H. J. Larson, K. J. Looker, R. Lunevicius, R. A. Lyons, W. Marcenes, A. J. Mason-Jones, F. E. Matthews, H. Moller, M. E. Murdoch, C. R. Newton, N. Pearce, F. B. Piel, D. Pope, K. Rahimi, A. Rodriguez, P. Scarborough, A. E. Schumacher, I. Shiue, L. Smeeth, A. Tedstone, J. Valabhji, H. C. Williams, C. D. A. Wolfe, A. D. Woolf, A. C. J. Davis |
| |
Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals | K. T. Nead, A. Li, M. R. Wehner, B. Neupane, S. Gustafsson, A. Butterworth, J. C. Engert, A. D. Davis, R. A. Hegele, R. Miller, M. den Hoed, K.-T. Khaw, T. O. Kilpeläinen, N. Wareham, T. L. Edwards, G. Hallmans, T. V. Varga, S. L. R. Kardia, J. A. Smith, W. Zhao, J. D. Faul, D. Weir, J. Mi, B. Xi, S. Canizales Quinteros, C. Cooper, A. A. Sayer, K. Jameson, A. Grøntved, M. Fornage, S. Sidney, C. L. Hanis, H. M. Highland, H.-U. Häring, M. Heni, J. Lasky-Su, S. T. Weiss, G. S. Gerhard, C. Still, M. M. Melka, Z. Pausova, T. Paus, S. F. A. Grant, H. Hakonarson, R. Arlen Price, K. Wang, A. Scherag, J. Hebebrand, A. Hinney, B. Japan, AGEN-BMI, GIANT Consortium, P. W. Franks, T. M. Frayling, M. I. McCarthy, J. N. Hirschhorn, R. J. Loos, E. Ingelsson, H. C. Gerstein, S. Yusuf, J. Beyene, S. S. Anand, D. Meyre |
| |
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition | GBD 2013 DALYs and HALE Collaborators |
| |
Vitamin D and bone development | R. J. Moon, N. C. Harvey, J. H. Davies, C. Cooper |
| |
Validity of parental recall of children’s fracture: implications for investigation of childhood osteoporosis | R. J. Moon, A. Lim, M. Farmer, A. Segaran, N. M. P. Clarke, N. C. Harvey, C. Cooper, J. H. Davies |
| |
Tracking of 25-hydroxyvitamin D status during pregnancy: the importance of vitamin D supplementation | R. J. Moon, S. R. Crozier, E. M. Dennison, J. H. Davies, S. M. Robinson, H. M. Inskip, K. M. Godfrey, C. Cooper, N. C. Harvey |
| |
Longitudinal changes in lean mass predict pQCT measures of tibial geometry and mineralisation at 6–7 years | R. J. Moon, Z. A. Cole, S. R. Crozier, E. M. Curtis, J. H. Davies, C. L. Gregson, S. M. Robinson, E. M. Dennison, K. M. Godfrey, H. M. Inskip, C. Cooper, N. C. Harvey, The Southampton Women's Survey Study Group |
| |
Influence of maternal vitamin D status on obstetric outcomes and the foetal skeleton | R. J. Moon, N. C. Harvey, C. Cooper |
| |
Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom | R. J. Moon, N. C. Harvey, E. M. Curtis, F. de Vries, T. van Staa, C. Cooper |
| |
Differences in childhood adiposity influence upper limb fracture site | R. J. Moon, A. Lim, M. Farmer, A. Segaran, N. M. P. Clarke, E. M. Dennison, N. C. Harvey, C. Cooper, J. H. Davies |
| |
Life-course approach to nutrition | P. J. Mitchell, C. Cooper, B. Dawson-Hughes, C. M. Gordon, R. Rizzoli |
| |
Metabolomic Identication of a Novel Pathway of Blood Pressure Regulation Involving Hexadecanedioate | C. Menni, D. Graham, G. Kastenmüller, N. H. J. Alharbi, S. M. D. Alsanosi, M. McBride, M. Mangino, P. Titcombe, S.-Y. Shin, M. Psatha, T. Geisendorfer, A. Huber, A. Peters, R. Wang-Sattler, T. Xu, M. J. Brosnan, J. Trimmer, C. Reichel, R. P. Mohney, N. Soranzo, M. H. Edwards, C. Cooper, A. C. Church, K. Suhre, C. Gieger, A. F. Dominiczak, T. D. Spector, S. Padmanabhan, A. M. Valdes |
| |
FRAX-based assessment and intervention thresholds— an exploration of thresholds in women aged 50 years and older in the UK | E. McCloskey, J. A. Kanis, H. Johansson, N. Harvey, A. Odén, A. Cooper, C. Cooper, R. M. Francis, D. M. Reid, D. Marsh, P. Selby, F. Thompson, S. Hewitt, J. Compston |
| |
Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study | D. Martinez-Laguna, C. Tebe, M. K. Javaid, X. Nogues, N. K. Arden, C. Cooper, A. Diez-Perez, D. Prieto-Alhambra |
| |
Does Combined Clinical and Ultrasound Assessment Allow Selection of Individuals With Rheumatoid Arthritis for Sustained Reduction of Anti–Tumor Necrosis Factor Therapy? | J. L. MARKS, C. R. HOLROYD, B. D. DIMITROV, R. D. ARMSTRONG, A. CALOGERAS, C. COOPER, B. K. DAVIDSON, E. M. DENNISON, N. C. HARVEY, C. J. EDWARDS |
| |
Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis | S. Mansour, A. S. Tocheva, J. P. Sanderson, L. M. Goulston, H. Platten, L. Serhal, C. Parsons, M. H. Edwards, C. H. Woelk, P. T. Elkington, T. Elliott, C. Cooper, C. J. Edwards, S. D. Gadola |
| |
Antenatal blood pressure for prediction of pre-eclampsia, preterm birth, and small for gestational age babies: development and validation in two general population cohorts | C. Macdonald-Wallis, R. J. Silverwood, B. L. de Stavola, H. Inskip, C. Cooper, K. M. Godfrey, S. Crozier, A. Fraser, S. M. Nelson, D. A. Lawlor, K. Tilling |
| |
Non-invasive Assessment of Lower Limb Geometry and Strength Using Hip Structural Analysis and Peripheral Quantitative Computed Tomography: A Population-Based Comparison | A. E. Litwic, M. Clynes, H. J. Denison, K. A. Jameson, M. H. Edwards, A. A. Sayer, P. Taylor, C. Cooper, E. M. Dennison |
| |
Obesity and the Relative Risk of Knee Replacement Surgery in Patients With Knee Osteoarthritis | K. M. Leyland, A. Judge, M. K. Javaid, A. Diez-Perez, A. Carr, C. Cooper, N. K. Arden, D. Prieto-Alhambra |
| |
Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD | A. Lewis, J. Y. Lee, A. V. Donaldson, S. A. Natanek, S. Vaidyanathan, W. D.-C. Man, N. S. Hopkinson, A. A. Sayer, H. P. Patel, C. Cooper, H. Syddall, M. I. Polkey, P. R. Kemp |
| |
Impact of hip fracture on hospital care costs: a population-based study | J. Leal, A. M. Gray, D. Prieto-Alhambra, N. K. Arden, C. Cooper, M. K. Javaid, A. Judge, The REFReSH study group |
| |
‘Making every contact count’: Evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change | W. Lawrence, C. Black, T. Tinati, S. Cradock, R. Begum, M. Jarman, A. Pease, B. Margetts, J. Davies, H. Inskip, C. Cooper, J. Baird, M. Barker |
| |
Statins and Risk of Lower Limb Revision Surgery: The Influence of Differences in Study Design Using Electronic Health Records From the United Kingdom and Denmark | A. Lalmohamed, T. P. van Staa, P. Vestergaard, H. G. M. Leufkens, A. de Boer, P. Emans, C. Cooper, F. de Vries |
| |
A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes | E. J. Kucharz, V. Kovalenko, S. Szántó, O. Bruyère, C. Cooper, J.-Y. Reginster |
| |
Pubertal timing and bone phenotype in early old age: findings from a British birth cohort study | D. Kuh, S. G. Muthuri, A. Moore, T. J. Cole, J. E. Adams, C. Cooper, R. Hardy, K. A. Ward |
| |
Painful knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-up of a population-based cohort of middle-aged women | S. Kluzek, M. T. Sanchez-Santos, K. M. Leyland, A. Judge, T. D. Spector, D. Hart, C. Cooper, J. Newton, N. K. Arden |
| |
SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture | J. A. Kanis, J. Compston, C. Cooper, N. C. Harvey, H. Johansson, A. Odén, E. V. McCloskey |
| |
A systematic review of intervention thresholds based on FRAX | J. A. Kanis, N. C. Harvey, C. Cooper, H. Johansson, A. Odén, E. V. McCloskey, The Advisory Board of the National Osteoporosis Guideline Group |
| |
Site-Dependent Reference Point Microindentation Complements Clinical Measures for Improved Fracture Risk Assessment at the Human Femoral Neck | T. Jenkins, L. V. Coutts, S. D’Angelo, D. G. Dunlop, R. O. C. Oreffo, C. Cooper, N. C. Harvey, P. J. Thurner, the Observational Study Examining Osteoporosis (OStEO) group |
| |
Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12 | V. E. Jackson, I. Ntalla, I. Sayers, R. Morris, P. Whincup, J.-P. Casas, A. Amuzu, M. Choi, C. Dale, M. Kumari, J. Engmann, N. Kalsheker, S. Chappell, T. Guetta-Baranes, T. M. McKeever, C. N. A. Palmer, R. Tavendale, J. W. Holloway, A. A. Sayer, E. M. Dennison, C. Cooper, M. Bafadhel, B. Barker, C. Brightling, C. E. Bolton, M. E. John, S. G. Parker, M. F. Moffat, A. J. Wardlaw, M. J. Connolly, D. J. Porteous, B. H. Smith, S. Padmanabhan, L. Hocking, K. E. Stirrups, P. Deloukas, D. P. Strachan, I. P. Hall, M. D. Tobin, L. V. Wain |
| |
Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus | F. S. Hough, D. D. Pierroz, C. Cooper, S. L. Ferrari, The IOF CSA Bone and Diabetes Working Group |
| |
Placental Size Is Associated Differentially With Postnatal Bone Size and Density | C. R. Holroyd, C. Osmond, D. J. P. Barker, S. M. Ring, D. A. Lawlor, J. H. Tobias, G. D. Smith, C. Cooper, N. C. Harvey |
| |
Age at introduction of solid foods and feeding difficulties in childhood: findings from the Southampton Women’s Survey | J. L. Hollis, S. R. Crozier, H. M. Inskip, C. Cooper, K. M. Godfrey, S. M. Robinson, Southampton Women’s Survey Study Group |
| |
Physical Activity Patterns Among Older Adults With and Without Knee Osteoarthritis in Six European Countries | F. HERBOLSHEIMER, L. A. SCHAAP, M. H. EDWARDS, S. MAGGI, Á. OTERO, E. J. TIMMERMANS, M. D. DENKINGER, S. VAN DER PAS, J. DEKKER, C. COOPER, E. M. DENNISON, N. M. VAN SCHOOR, R. PETER, THE EPOSA STUDY GROUP |
| |
Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study | S. Hawley, M. K. Javaid, K. H. Rubin, A. Judge, N. K. Arden, P. Vestergaard, R. Eastell, A. Diez-Perez, C. Cooper, B. Abrahamsen, D. Prieto-Alhambra |
| |
Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study | S. HAWLEY, M. K. JAVAID, D. PRIETO-ALHAMBRA, J. LIPPETT, S. SHEARD, N. K. ARDEN, C. COOPER, A. JUDGE, THE REFRESH STUDY GROUP |
| |
On epidemiology of fractures and variation with age and ethnicity | N. C. Harvey, E. M. Curtis, R. van der Velde, R. J. Moon, J. P.W. van den Bergh, P. Geusens, F. de Vries, T. P. van Staa, C. Cooper |
| |
High-dose vitamin D supplementation does not alter bone mass or muscle function over 1 year in postmenopausal women | N. C. Harvey, C. Cooper |
| |
FRAX predicts incident falls in elderly men: findings from MrOs Sweden | N. C. Harvey, H. Johansson, A. Odén, M. K. Karlsson, B. E. Rosengren, Ö. Ljunggren, C. Cooper, E. McCloskey, J. A. Kanis, C. Ohlsson, D. Mellström |
| |
Developmental aspects of a life course approach to healthy ageing | M. A. Hanson, C. Cooper, A. Aihie Sayer, R. J. Eendebak, G. F. Clough, J. R. Beard |
| |
Harmonising data collection from osteoarthritis studies to enable stratification: recommendations on core data collection from an Arthritis Research UK clinical studies group | S. R. Kingsbury, N. Corp, F. E. Watt, D. T. Felson, T. W. O’Neill, C. A. Holt, R. K. Jones, P. G. Conaghan, Arthritis Research UK Osteoarthritis and Crystal Disease Clinical Studies Group working group, N. K. Arden |
| |
Recommendations for the conduct of efficacy trials of treatment devices for osteoarthritis: a report from a working group of the Arthritis Research UK Osteoarthritis and Crystal Diseases Clinical Studies Group | D. T. Felson, A. C. Redmond, G. J. Chapman, T. O. Smith, D. F. Hamilton, R. K. Jones, C. A. Holt, M. J. Callaghan, D. J. Mason, Arthritis Research UK Osteoarthritis and Crystal Diseases Clinical Studies Groupy, P. G. Conaghan |
| |
Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis | C. Reyes, K. M. Leyland, G. Peat, C. Cooper, N. K. Arden, D. Prieto-Alhambra |
| |
The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial | N. K. Arden, S. Cro, S. Sheard, C. J. Dore, A. Bara, S. A. Tebbs, D. J. Hunter, S. James, C. Cooper, T. W. O'Neill, A. Macgregor, F. Birrell, R. Keen |
| |
The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids | M. van Middelkoop, N. K. Arden, I. Atchia, F. Birrell, J. Chao, M. U. Rezende, R. G. W. Lambert, P. Ravaud, J. W. Bijlsma, M. Doherty, K. S. Dziedzic, L. S. Lohmander, T. E. McAlindon, W. Zhang, S. M. A. Bierma-Zeinstra |
| |
Strategies for the prevention of knee osteoarthritis | E. M. Roos, N. K. Arden |
| |
Measures of hip morphology are related to development of worsening radiographic hip osteoarthritis over 6 to 13 year follow-up: the Johnston County Osteoarthritis Project | A. E. Nelson, J. L. Stiller, X. A. Shi, K. M. Leyland, J. B. Renner, T. A. Schwartz, N. K. Arden, J. M. Jordan |
| |
Obesity and the Relative Risk of Knee Replacement Surgery in Patients With Knee Osteoarthritis | K. M. Leyland, A. Judge, M. K. Javaid, A. Diez-Perez, A. Carr, C. Cooper, N. K. Arden, D. Prieto-Alhambra |
| |
Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women | S. Kluzek, A.-C. Bay-Jensen, A. Judge, M. A. Karsdal, M. Shorthose, T. Spector, D. Hart, J. L. Newton, N. K. Arden |
| |
Predictors of Patient-Reported Pain and Functional Outcomes Over 10 Years After Primary Total Knee Arthroplasty: A Prospective Cohort Study | Y. Jiang, M. T. Sanchez-Santos, A. D. Judge, D. W. Murray, N. K. Arden |
| |
High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study | M. H. Edwards, C. Parsons, O. Bruyère, F. Petit Dop, R. Chapurlat, F. W. Roemer, A. Guermazi, S. Zaim, H. Genant, J.-Y. Reginster, E. M. Dennison, C. Cooper, The SEKOIA Study Group |
| |
Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis | S. Hawley, J. Leal, A. Delmestri, D. Prieto-Alhambra, N. K. Arden, C. Cooper, M. K. Javaid, A. Judge for the REFReSH Study Group |
| |
A comparison of radiographic anatomic axis knee alignment measurements and cross-sectional associations with knee osteoarthritis | L. M. Goulston, M. T. Sanchez-Santos, S. D'Angelo, K. M. Leyland, D. J. Hart, T. D. Spector, C. Cooper, E. M. Dennison, D. Hunter, N. K. Arden |
| |
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial | C. Cooper, N. C. Harvey, N. J. Bishop, S. Kennedy, A. T. Papageorghiou, I. Schoenmakers, R. Fraser, S. V. Gandhi, A. Carr, S. D’Angelo, S. R. Crozier, R. J. Moon, N. K. Arden, E. M. Dennison, K. M. Godfrey, H. M. Inskip, A. Prentice, M. Z. Mughal, R. Eastell, D. M. Reid, M. K. Javaid, the MAVIDOS Study Group |
| |
Mortality rates at 10 years after metal-on-metal hip resurfacing compared with total hip replacement in England | A. R. Kendal, D. Prieto-Alhambra, N. K. Arden, A. Carr, A. Judge |
| |
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty | N. Arden, P. Richette, C. Cooper, O. Bruyère, E. Abadie, J. Branco, M. L. Brandi, F. Berenbaum, C. Clerc, E. Dennison, J.-P. Devogelaer, M. Hochberg, P. D’Hooghe, G. Herrero-Beaumont, J. A. Kanis, A. Laslop, V. Leblanc, S. Maggi, G. Mautone, J.-P. Pelletier, F. Petit-Dop, S. Reiter-Niesert, R. Rizzoli, L. Rovati, E. Tajana Messi, Y. Tsouderos, J. Martel-Pelletier, J.-Y. Reginster |
| |
Painful knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-up of a population-based cohort of middle-aged women | S. Kluzek, M. T. Sanchez-Santos, K. M. Leyland, A. Judge, T. D. Spector, D. Hart, C. Cooper, J. Newton, N. K. Arden |
| |
Transfer factor, lung volumes, resistance and ventilation distribution in healthy adults | S. Verbanck, A. Van Muylem, D. Schuermans, I. Bautmans, B. Thompson, W. Vincken |
| |
Low- and High-Resistance Exercise: Long-Term Adherence and Motivation among Older Adults | E. Van Roie, I. Bautmans, W. Coudyzer, F. Boen, C. Delecluse |
| |
Predicting appendicular lean and fat mass with bioelectrical impedance analysis in older adults with physical function decline - The PROVIDE study | A. Scafoglieri, J. Pieter Clarys, J. M. Bauer, S. Verlaan, L. Van Malderen, S. Vantieghem, T. Cederholm, C. C. Sieber, T. Mets, I. Bautmans on behalf of the Provide Study Group |
| |
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia | J.-Y. Reginster, C. Cooper, R. Rizzoli, J. A. Kanis, G. Appelboom, I. Bautmans, H. A. Bischoff-Ferrari, M. Boers, M. L. Brandi, O. Bruyère, A. Cherubini, B. Flamion, R. A. Fielding, A. Ildiko Gasparik, L. Van Loon, E. McCloskey, B. H. Mitlak, A. Pilotto, S. Reiter-Niesert, Y. Rolland, Y. Tsouderos, M. Visser, A. J. Cruz-Jentoft |
| |
Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study | O. Okwudiri Onyema, L. Decoster, R. Njemini, L. Nuvagah Forti, I. Bautmans, M. De Waele, T. Mets |
| |
Aging-associated subpopulations of human CD8+ T-lymphocytes identified by their CD28 and CD57 phenotypes | O. Okwudiri Onyema, R. Njemini, L. Nuvagah Forti, I. Bautmans, J. L. Aerts, M. De Waele, T. Mets |
| |
Chemotherapy-induced Changes and Immunosenescence of CD8+ T-Cells in Patients with Breast Cancer | O. Okwudiri Onyema, L. Decoster, R. Njemini, L. Nuvagah Forti, I. Bautmans, M. De Waele, T. Mets |
| |
Load-Specific Inflammation Mediating Effects of Resistance Training in Older Persons | L. Nuvagah Forti, E. Van Roie, R. Njemini, W. Coudyzer, I. Beyer, C. Delecluse, I. Bautmans |
| |
Dose-and gender-specific effects of resistance training on circulating levels of brain derived neurotrophic factor (BDNF) in community-dwelling older adults | L. Nuvagah Forti, E. Van Roie, R. Njemini, W. Coudyzer, I. Beyer, C. Delecluse, I. Bautmans |
| |
The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function | H. Drenth, S. Zuidema, S. Bunt, I. Bautmans, C. van der Schans, H. Hobbelen |
| |
Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells | K. De Veirman, J. A. Van Ginderachter, S. Lub, N. De Beule, K. Thielemans, I. Bautmans, B. O. Oyajobi, E. De Bruyne, E. Menu, M. Lemaire, I. Van Riet, K. Vanderkerken, E. Van Valckenborgh |
| |
Validity and test-retest reliability of the Stride Analyzer in people with knee osteoarthritis | D. Beckwée, M. Degelaen, M. Eggermont, M. Gonzalez-Rodriguez, N. Lefeber, P. Vaes, I. Bautmans, E. Swinnen |
| |
Exercise in knee osteoarthritis: do treatment outcomes relate to bone marrow lesions? A randomized trial | D. Beckwée, P. Vaes, S. Raeymaeckers, M. Shahabpour, T. Scheerlinck, I. Bautmans |
| |
Exercise in knee osteoarthritis – preliminary findings: Exercise-induced pain and health status differs between drop-outs and retainers | D. Beckwée, I. Bautmans, T. Scheerlinck, P. Vaes |
| |
The Influence of Joint Loading on Bone Marrow Lesions in the Knee: A Systematic Review With Meta-analysis | D. Beckwée, P. Vaes, M. Shahabpour, R. Muyldermans, N. Rommers, I. Bautmans |
| |
Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL | C. Beaudart, E. Biver, J.-Y. Reginster, R. Rizzoli, Y. Rolland, I. Bautmans, J. Petermans, S. Gillain, F. Buckinx, J. Van Beveren, M. Jacquemain, P. Italiano, N. Dardenne, O. Bruyère |
| |
Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial | J. M. Bauer, S. Verlaan, I. Bautmans, K. Brandt, L. M. Donini, M. Maggio, M. E. T. McMurdo, T. Mets, C. Seal, S. L. Wijers, G. P. Ceda, G. De Vito, G. Donders, M. Drey, C. Greig, U. Holmbäck, M. Narici, J. McPhee, E. Poggiogalle, D. Power, A. Scafoglieri, R. Schultz, C. C. Sieber, T. Cederholm |
| |
An Administrator’s Perspective on the Organization of Physical Activity for Older Adults in Long-Term Care Facilities | V. Baert, E. Gorus, K. Calleeuw, W. De Backer, I. Bautmans |
| |
Motivators and Barriers for Physical Activity in Older Adults With Osteoporosis | V. Baert, E. Gorus, T. Mets, I. Bautmans |
| |
Physiotherapists’ Perceived Motivators and Barriers for Organizing Physical Activity for Older Long-Term Care Facility Residents | V. Baert, E. Gorus, N. Guldemont, S. De Coster, I. Bautmans |
| |
Age-related differences in muscle recruitment and reaction-time performance | P. Arnold, S. Vantieghem, E. Gorus, E. Lauwers, Y. Fierens, A. Pool-Goudzwaard, I. Bautmans |
| |
The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliability | X. Torres, A. Collado, E. Gómez, A. Arias, S. Cabrera-Villalba, O. D. Messina, L. F. Vidal, P. Clark, C. Ríos, P. A. Salomón |
| |
The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American Countries | A. Collado, X. Torres, O. D. Messina, L. F. Vidal, P. Clark, Carlos Ríos, E. Solé, A. Arias, S. Perrot, P. A. Salomon |
| |
Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees | M. Hars, E. Biver, T. Chevalley, F. Herrmann, R. Rizzoli, S. Ferrari, A. Trombetti |
| |
Periostin action in bone | N. Bonnet, P. Garnero, S. Ferrari |
| |
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club | E. Cavalier, P. Bergmann, O. Bruyère, P. Delanaye, A. Durnez, J.-P. Devogelaer, S. L. Ferrari, E. Gielen, S. Goemaere, J.-M. Kaufman, A. Nzeusseu Toukap, J.-Y. Reginster, A.-F. Rousseau, S. Rozenberg, A. J. Scheen, J.-J. Body |
| |
Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus | F. S. Hough, D. D. Pierroz, C. Cooper, S. L. Ferrari, The IOF CSA Bone and Diabetes Working Group |
| |
Taxonomy of rare genetic metabolic bone disorders | L. Masi, D. Agnusdei, J. Bilezikian, D. Chappard, R. Chapurlat, L. Cianferotti, J.-P. Devolgelaer, A. El Maghraoui, S. Ferrari, M. K. Javaid, J.-M. Kaufman, U. A. Liberman, G. Lyritis, P. Miller, N. Napoli, E. Roldan, S. Papapoulos, N. B. Watts, M. L. Brandi |
| |
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice | N. Bonnet, M. Gerbaix, M. Ominsky, P. Ammann, P. J. Kostenuik, S. L. Ferrari |
| |
Occupation-dependent loading increases bone strength in men | E. Biver, G. Perréard Lopreno, M. Hars, B. van Rietbergen, J. P. Vallée, S. Ferrari, M. Besse, R. Rizzoli |
| |
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial | C. Becker, S. R. Lord, S. A. Studenski, S. J. Warden, R. A. Fielding, C. P. Recknor, M. C. Hochberg, S. L. Ferrari, H. Blain, E. F. Binder, Y. Rolland, S. Poiraudeau, C. T. Benson, S. L. Myers, L. Hu, Q. I. Ahmad, K. R. Pacuch, E. V. Gomez, O. Benichou on behalf of the STEADY Group |
| |
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years | S. Ferrari, J. D. Adachi, K. Lippuner, C. Zapalowski, P. D. Miller, J.-Y. Reginster, O. Törring, D. L. Kendler, N. S. Daizadeh, A. Wang, C. D. O’Malley, R. B. Wagman, C. Libanati, E. M. Lewiecki |
| |
Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure | N. Bonnet, E. Biver, C. Durosier, T. Chevalley, R. Rizzoli, S. Ferrari |
| |
Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations | E. Biver, C. Durosier, T. Chevalley, F. R. Herrmann, S. Ferrari, R. Rizzoli |
| |
Periostin expression contributes to cortical bone loss during unloading | M. Gerbaix, L. Vico, S. L. Ferrari, N. Bonnet |
| |
Critical analytical evaluation of promising markers for sarcopenia | E. Cavalier, C. Beaudart, F. Buckinx, O. Bruyère, J.-Y. Reginster |
| |
The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians | J. Paccou, P. Hardouin, A. Cotten, G. Penel, B. Cortet |
| |
Trabecular Bone Score: Where are we now? | V. Bousson, C. Bergot, B. Sutter, T. Thomas, S. Bendavid, C.-L. Benhamou, H. Blain, M. Brazier, V. Breuil, K. Briot, R. Chapurlat, L. Chapuis, M. Cohen Solal, P. Fardellone, J.-M. Feron, J.-B. Gauvain, M. Laroche, E. Legrand, E. Lespessailles, A. Linglart, C. Marcelli, C. Roux, J.-C. Souberbielle, F. Tremollieres, G. Weryha, B. Cortet, Groupe de Recherche et d’Information sur les Ostéoporoses (GRIO) |
| |
Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study | A. Modi, S. Sen, J. D. Adachi, S. Adami, B. Cortet, A. L. Cooper, P. Geusens, D. Mellström, J. Weaver, J. P. van den Bergh, A. M. Nguyen, S. Sajjan, MUSIC-OS Study Group |
| |
Bone Samples Extracted from Embalmed Subjects Are Not Appropriate for the Assessment of Bone Quality at the Molecular Level Using Raman Spectroscopy | T. Pascart, B. Cortet, C. Olejnik, J. Paccou, H. Migaud, A. Cotten, Y. Delannoy, A. During, P. Hardouin, G. Penel, G. Falgayrac |
| |
TBS and bone strength | B. Cortet, V. Bousson |
| |
Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study | T. Pascart, P. Philippe, E. Drumez, X. Deprez, B. Cortet, A. Duhamel, E. Houvenagel, R.-M. Flipo |
| |
Trabecular Bone Score and Osteoporotic Fractures in Obese Postmenopausal Women | M.-L. Ayoub, G. Maalouf, B. Cortet, I. Legroux-Gérout, G. Zunquin, R. El Hage |
| |
Secondary prevention program for osteoporotic fractures at Lille University Hospital | N. Abbad, L. Lemeunier, C. Chantelot, F. Puisieux, B. Cortet |
| |
Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis | B. Cortet, A. Modi, J. Tang, C.-P. S. Fan, S. Sajjan, J. Papadopoulos Weaver |
| |
Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect | C. Olejnik, G. Falgayrac, A. During, B. Cortet, G. Penel |
| |
A COMPREHENSIVE FRACTURE PREVENTION STRATEGY IN OLDER ADULTS: THE EUROPEAN UNION GERIATRIC MEDICINE SOCIETY (EUGMS) STATEMENT | H. BLAIN, T. MASUD, P. DARGENT-MOLINA, F.C. MARTIN, E. ROSENDAHL, N. VAN DER VELDE, J. BOUSQUET, A. BENETOS, C. COOPER, J. A. KANIS, J.Y. REGINSTER, R. RIZZOLI, B. CORTET, M. BARBAGALLO, K.E. DREINHÖFER, B. VELLAS, S. MAGGI, T. STRANDBERG, FOR THE EUGMS FALLS AND FRACTURE INTEREST GROUP, THE INTERNATIONAL ASSOCIATION OF GERONTOLOGY AND GERIATRICS FOR THE EUROPEAN REGION (IAGG-ER), THE EUROPEAN UNION OF MEDICAL SPECIALISTS (EUMS), THE FRAGILITY FRACTURE NETWORK (FFN), THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO), AND THE INTERNATIONAL OSTEOPOROSIS FOUNDATION (IOF) |
| |
Does low bone mineral density predict mortality? | B. Cortet |
| |
Reimbursment of the serum CTX assay in France: the clinical biology nomenclature is incoherent | J.-C. Souberbielle, S. Bendavid, H. Blain, V. Bousson, V. Breuil, K. Briot, R. Chapurlat, L. Chapuis, M. Cohen-Solal, P. Fardellone, J.-M. Feron, J.-B. Gauvain, M. Laroche, E. Legrand, E. Lespessailles, A. Linglart, C. Marcelli, C. Roux, B. Sutter, T. Thomas, F. Trémollières, G. Weryha, B. Cortet |
| |
Management after first-line antiresorptive treatment for postmenopausal osteoporosis | J. Paccou |
| |
Lower leg arterial calcification assessed by high-resolution peripheral quantitative computed tomography is associated with bone microstructure abnormalities in women | J. Paccou, M. H. Edwards, J. M. Patsch, K. A. Jameson, K. A. Ward, C. Moss, E. M. Dennison, C. Cooper |
| |
The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians | J. Paccou, P. Hardouin, A. Cotten, G. Penel, B. Cortet |
| |
Relationships between bone geometry, volumetric bone mineral density and bone microarchitecture of the distal radius and tibia with alcohol consumption | J. Paccou, M. H. Edwards, K. Ward, K. Jameson, R. Moon, E. Dennison, C. Cooper |
| |
Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition | G. Bahat, A. Tufan, F. Tufan, C. Kilic, T. Selçuk Akpinar, M. Kose, N. Erten, M. Akif Karan, A. J. Cruz-Jentoft |
| |
Energy and nutrient content of food served and consumed by nursing home residents | F. Buckinx, S. Allepaerts, N. Paquot, J.-Y. Reginster, C. De Cock, J. Petermans, O. Bruyère |
| |
Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners | F. Buckinx, J. Y. Reginster, E. Cavalier, J. Petermans, C. Ricour, C. Dardenne, O. Bruyère |
| |
Relationship between frailty, physical performance and quality of life among nursing home residents: the SENIOR cohort | F. Buckinx, J.-Y. Reginster, J. Petermans, J. L. Croisier, C. Beaudart, T. Brunois, O. Bruyère |
| |
Incidence of hip fracture in Brazil and the development of a FRAX model | C. A. F. Zerbini, V. L. Szejnfeld, B. H. Abergaria, E. V. McCloskey, H. Johansson, J. A. Kanis |
| |
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO | K. Pavelka, O. Bruyère, C. Cooper, J. A. Kanis, B. F. Leeb, E. Maheu, J. Martel-Pelletier, J. Monfort, J.-P. Pelletier, R. Rizzoli, J.-Y. Reginster |
| |
Burden of high fracture probability worldwide: secular increases 2010–2040 | A. Odén, E. V. McCloskey, J. A. Kanis, N. C. Harvey, H. Johansson |
| |
Clinical usefulness of bone turnover marker concentrations in osteoporosis | H. A. Morris, R. Eastell, N. R. Jorgesen, E. Cavalier, S. Vasikaran, S. A. P. Chubb, J. A. Kanis, C. Cooper, K. Makris on behalf of the IFCC-IOF Working Group for Standardisation of Bone Marker Assays (WG-BMA) |
| |
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX | E. V. McCloskey, A. Odén, N. C. Harvey, W. D. Leslie, D. Hans, H. Johansson, R. Barkmann, S. Boutroy, J. Brown, R. Chapurlat, P. J. M. Elders, Y. Fujita, C.-C. Glüer, D. Goltzman, M. Iki, M. Karlsson, A. Kindmark, M. Kotowicz, N. Kurumatani, T. Kwok, O. Lamy, J. Leung, K. Lippuner, Ö. Ljunggren, M. Lorentzon, D. Mellström, T. Merlijn, L. Oei, C. Ohlsson, J. A. Pasco, F. Rivadeneira, B. Rosengren, E. Sornay-Rendu, P. Szulc, J. Tamaki, J. A. Kanis |
| |
Can we treat to target in osteoporosis? | E. V. McCloskey, N. C. Harvey, J. A. Kanis |
| |
Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis | E. V. McCloskey, J. A. Kanis, A. Odén, N. C. Harvey, D. Bauer, J. González-Macias, D. Hans, S. Kaptoge, M. A. Krieg, T. Kwok, F. Marin, A. Moayyeri, E. Orwoll, C. Gluёr, H. Johansson |
| |
Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX in Portugal | A. Marques, Ó. Lourenço, G. Ortsäter, F. Borgström, J. A. Kanis, J. A. P. da Silva |
| |
Hip Axis Length is a FRAX and Bone Density Independent Risk Factor for Hip Fracture in Women | W. D. Leslie, L. M. Lix, S. N. Morin, H. Johansson, A. Odén, E. V. McCloskey, J. A. Kanis |
| |
SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture | J. A. Kanis, J. Compston, C. Cooper, N. C. Harvey, H. Johansson, A. Odén, E. V. McCloskey |
| |
A systematic review of intervention thresholds based on FRAX | J. A. Kanis, N. C. Harvey, C. Cooper, H. Johansson, A. Odén, E. V. McCloskey, The Advisory Board of the National Osteoporosis Guideline Group |
| |
Intervention Thresholds and the Diagnosis of Osteoporosis | J. A. Kanis, E. V. McCloskey, N. C. Harvey, H. Johansson, W. D. Leslie |
| |
FRAX and fracture prediction without bone mineral density | J. A. Kanis, N. C. Harvey, H. Johansson, A. Odén, W. D. Leslie, E. V. McCloskey |
| |
Quality of life, resource use, and costs related to hip fracture in Estonia | M. Jürisson, H. Pisarev, J. Kanis, F. Borgström, A. Svedbom, R. Kallikorm, M. Lember, A. Uusküla |
| |
Is the Swedish FRAX model appropriate for Swedish immigrants? | H. Johansson, A. Odén, M. Lorentzon, E. McCloskey, J. A. Kanis, N. C. Harvey, M. K. Karlsson, D. Mellström |
| |
FRAX predicts incident falls in elderly men: findings from MrOs Sweden | N. C. Harvey, H. Johansson, A. Odén, M. K. Karlsson, B. E. Rosengren, Ö. Ljunggren, C. Cooper, E. McCloskey, J. A. Kanis, C. Ohlsson, D. Mellström |
| |
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice | N. C. Harvey, C. C. Glüer, N. Binkley, E. V. McCloskey, M.-L. Brandi, C. Cooper, D. Kendler, O. Lamy, A. Laslop, B. M. Camargos, J.-Y. Reginster, R. Rizzoli, J. A. Kanis |
| |
FRAX and the effect of teriparatide on vertebral and non-vertebral fracture | N. C. Harvey, J. A. Kanis, A. Odén, R. T. Burge, B. H. Mitlak, H. Johansson, E. V. McCloskey |
| |
Sarcopenia, the last organ insufficiency | A. J. Cruz-Jentoft |
| |
Assessment of muscle mass, muscle strength and physical performance in clinical practice: An international survey | O. Bruyère, C. Beaudart, J.-Y. Reginster, F. Buckinx, D. Schoene, V. Hirani, C. Cooper, J. A. Kanis, R. Rizzoli, E. McCloskey, T. Cederholm, A. Cruz-Jentoft, E. Freiberger |
| |
A New Concept of Health Can Improve the Definition of Frailty | M. Boers, A. J. Cruz Jentoft |
| |
Frailty, Exercise and Nutrition | J.-P. Michel, A. J. Cruz-Jentoft, T. Cederholm |
| |
Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis | B. Stiburkova, H. Miyata, J. Závada, M. Tomčík, K. Pavelka, G. Storkanova, Y. Toyoda, T. Takada, H. Suzuki |
| |
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study | C. Peterfy, P. Emery, P. P. Tak, M. Østergaard, J. DiCarlo, K. Otsa, F. Navarro Sarabia, K. Pavelka, M.-A. Bagnard, L. Hinsch Gylvin, C. Bernasconi, A. Gabriele |
| |
Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis | L. Šenolt, B. Šumová, R. Jandová, H. Hulejová, H. Mann, K. Pavelka, J. Vencovský, M. Filková |
| |
Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgaris | M. Husakova, J. Lippert, J. Stolfa, L. Sedova, P. Arenberger, Z. Lacinova, K. Pavelka |
| |
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO | K. Pavelka, O. Bruyère, C. Cooper, J. A. Kanis, B. F. Leeb, E. Maheu, J. Martel-Pelletier, J. Monfort, J.-P. Pelletier, R. Rizzoli, J.-Y. Reginster |
| |
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology | M. H. Buch, L. Silva-Fernandez, L. Carmona, D. Aletaha, R. Christensen, B. Combe, P. Emery, G. Ferraccioli, F. Guillemin, T. K. Kvien, R. Landewe, K. Pavelka, K. Saag, J. S. Smolen, D. Symmons, D. van der Heijde, J. Welling, G. Wells, R. Westhovens, A. Zink, M. Boers |
| |
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study | J. Závada, M. Uher, K. Sisol, Š. Forejtová, K. Jarošová, H. Mann, J. Vencovský, K. Pavelka |
| |
A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate | K. Pavelka, Y. Chon, R. Newmark, S.-L. Lin, S. Baumgartner, N. Erondu |
| |
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases | R. von Moos, J.-J. Body, B. Egerdie, A. Stopeck, J. Brown, L. Fallowfield, D. L. Patrick, C. Cleeland, D. Damyanov, F. Salvador Palazzo, G. Marx, Y. Zhou, A. Braun, A. Balakumaran, Y. Qian |
| |
Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom | G. Hechmati, A. Brett Hauber, J. Arellano, A. F. Mohamed, Y. Qian, F. Gatta, I. Haynes, A. Bahl, R. von Moos, J.-J. Body |
| |
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease | I. J. Diel, J.-J. Body, A. T. Stopeck, S. Vadhan-Raj, A. Spencer, G. Stegerf, R. von Moos, F. Goldwasser, A. Feng, A. Braun |
| |
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club | E. Cavalier, P. Bergmann, O. Bruyère, P. Delanaye, A. Durnez, J.-P. Devogelaer, S. L. Ferrari, E. Gielen, S. Goemaere, J.-M. Kaufman, A. Nzeusseu Toukap, J.-Y. Reginster, A.-F. Rousseau, S. Rozenberg, A. J. Scheen, J.-J. Body |
| |
Hypocalcaemia in patients with metastatic bone disease treated with denosumab | J.-J. Body, H. G. Bone, R. H. de Boer, A. Stopeck, C. Van Poznak, R. Damião, K. Fizazi, D. H. Henry, T. Ibrahim, A. Lipton, F. Saad, N. Shore, T. Takano, A. J. Shaywitz, H. Wang, O. L. Bracco, A. Braun, P. J. Kostenuik |
| |
Health resource utilization associated with skeletal-related events: results from a retrospective European study | J.-J. Body, J. Pereira, H. Sleeboom, N. Maniadakis, E. Terpos, Y. P. Acklin, J. Finek, O. Gunther, G. Hechmati, T. Mossman, L. Costa, W. Rogowski, H. Nahi, R. von Moos |
| |
Targeting bone metastases in prostate cancer: improving clinical outcome | J.-J. Body, S. Casimiro and L. Costa |
| |
Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment | H. Penton, M. Hiligsmann, M. Harrison, J.-Y. Reginster, A. Boonen, N. Bansback |
| |
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures | O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster |
| |
The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis | M. Hiligsmann, G. Ronda, T. van der Weijden, A. Boonen |
| |
Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis | M. Hiligsmann, W. B. Sedrine, O. Bruyère, S. M. Evers, V. Rabenda, J.-Y. Reginster |
| |
A Review of Patient Preferences for Osteoporosis Drug Treatment | M. Hiligsmann, S. P. G. Bours, A. Boonen |
| |
Endocrine determinants of incident sarcopenia in middle-aged and elderly European men | E. Gielen, T. W. O’Neill, S. R. Pye, J. E. Adams, F. C. Wu, M. R. Laurent, F. Claessens, K. A. Ward, S. Boonen, R. Bouillon, D. Vanderschueren, S. Verschueren |
| |
Bone demineralisation in a large cohort of Wilson disease patients | K. H. Weiss, M. Van de Moortele, D. Nils Gotthardt, J. Pfeiffenberger, J. Seeßle, E. Ullrich, E. Gielen, H. Borghs, E. Adriaens, W. Stremmel, W. Meersseman, S. Boonen, D. Cassiman |
| |
Estrogens, the be-all and end-all of male hypogonadal bone loss? | M. R. Laurent, E. Gielen, D. Vanderschueren |
| |
Chronic widespread pain is associated with worsening frailty in European men | K. Fredrika Wade, D. M. Lee, J. McBeth, R. Ravindrarajah, E. Gielen, S. R. Pye, D. Vanderschueren, N. Pendleton, J. D. Finn, G. Bartfai, F. F. Casanueva, G. Forti, A. Giwercman, I. T. Huhtaniemi, K. Kula, M. Punab, F. C. W. Wu, T. W. O’Neill |
| |
Low heel ultrasound parameters predict mortality in men: results from the European Male Ageing Study (EMAS) | S. R. Pye, D. Vanderschueren, S. Boonen, E. Gielen, J. E. Adams, K. A. Ward, D. M. Lee, G. Bartfai, F. F. Casanueva, J. D. Finn, G. Forti, A. Giwercman, T. S. Han, I. T. Huhtaniemi, K. Kula, M. E. Lean, N. Pendleton, M. Punab, F. C. Wu, T. W. O’Neill |
| |
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study | P. Hadji, N. Papaioannou, E. Gielen, M. Feudjo Tepie, E. Zhang, I. Frieling, P. Geusens, P. Makras, H. Resch, G. Möller, L. Kalouche-Khalil, A. Fahrleitner-Pammer |
| |
Muscle-bone interactions: From experimental models to the clinic? A critical update | M. R. Laurent, V. Dubois, F. Claessens, S. M. P. Verschueren, D. Vanderschueren, E. Gielen, F. Jardí |
| |
How to manage an isolated elevated PTH? | J.-C. Souberbielle, E. Cavalier, C. Cormier |
| |
Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients | J.-C. Souberbielle, C. Massart, S. Brailly-Tabard, C. Cormier, E. Cavalier, P. Delanaye, P. Chanson |
| |
Serum calcitriol concentrations measured with a new direct automated assay in a large population of adult healthy subjects and in various clinical situations | J.-C. Souberbielle, E. Cavalier, P. Delanaye, C. Massart, S. Brailly-Tabard, C. Cormier, D. Borderie, A. Benachi, P. Chanson |
| |
A Randomized, Double-Blind, Parallel Study to Evaluate the Dose-Response of Three Different Vitamin D Treatment Schemes on the 25-Hydroxyvitamin D Serum Concentration in Patients with Vitamin D Deficiency | M.-L. Schleck, J.-C. Souberbielle, B. Jandrain, S. Da Silva, S. De Niet, F. Vanderbist, A. Scheen, Etienne Cavalier |
| |
Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: A one-year pilot randomized controlled trial in adults with severe burns | A.-F. Rousseau, M. Foidart-Desalle, D. Ledoux, C. Remy, J.-L. Croisier, P. Damas, E. Cavalier |
| |
Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use | P. Delanaye, E. Cavalier, A. Bouquegneau, A. Khwaja |
| |
Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients | P. Delanaye, J.-M. Krzesinski, X. Warling, M. Moonen, N. Smelten, L. Médart, O. Bruyère, J.-Y. Reginster, H. Pottel, E. Cavalier |
| |
Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts | P. Delanaye, J.-C. Souberbielle, M.-H. Lafage-Proust, G. Jean, E. Cavalier |
| |
Evaluation of circulating irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose | E. Cavalier, V. Mismetti, J.-C. Souberbielle |
| |
Critical analytical evaluation of promising markers for sarcopenia | E. Cavalier, C. Beaudart, F. Buckinx, O. Bruyère, J.-Y. Reginster |
| |
Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations | E. Cavalier, P. Delanaye, P. Lukas, A. Carlisi, R. Gadisseur, J.-C. Souberbielle |
| |
Inter-method variability in bone alkaline phosphatase measurement: Clinical impact on the management of dialysis patients | E. Cavalier, J.-C. Souberbielle, R. Gadisseur, B. Dubois, J.-M. Krzesinski, P. Delanaye |
| |
EVALUATION OF THE INTRA-INDIVIDUAL VARIABILITY OF MYOSTATIN AND ACTIVIN A, TWO BIOMARKERS OF SARCOPENIA: IMPACT ON THE LEAST SIGNIFICANT CHANGE AND FOLLOWUP OF THE PATIENTS | E. Cavalier, C. Piron, F. Watar, S. Kovacs, C. Beaudart, F. Buckinx, O. Bruyère, C. Le Goff, J.-Y. Reginster |
| |
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease | J. S. Smolen, S. Collaud Basset, M. Boers, F. Breedveld, C. J. Edwards, T. K. Kvien, P. Miossec, T. Sokka-Isler, R. F. van Vollenhoven, E. C. Abadie, O. Bruyère, C. Cooper, H. Mäkinen, T. Thomas, P. Tugwell, J.-Y. Reginster, on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) |
| |
A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis - From evidence-based medicine to the real-life setting | O. Bruyère, C. Cooper, J.-P. Pelletier, E. Maheu, F. Rannou, J. Branco, M. L. Brandi, J. A. Kanis, R. D. Altman, M. C. Hochberg, J. Martel-Pelletier, J.-Y. Reginster |
| |
A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes | E. J. Kucharz, V. Kovalenko, S. Szántó, O. Bruyère, C. Cooper, J.-Y. Reginster |
| |
Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC) | A. Neuprez, O. Bruyère, E. Maheu, N. Dardenne, N. Burlet, P. D’Hooghe, S. Distèche, J.-Y. Reginster |
| |
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) | C. Cooper, T. Bardin, M. L. Brandi, P. Cacoub, J. Caminis, R. Civitelli, M. Cutolo, W. Dere, J.-P. Devogelaer, A. Diez-Perez, T. A. Einhorn, P. Emonts, O. Ethgen, J. A. Kanis, J.-M. Kaufman, T. K. Kvien, W. F. Lems, E. McCloskey, P. Miossec, S. Reiter, J. Ringe, R. Rizzoli, K. Saag, J.-Y. Reginster |
| |
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures | O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster |
| |
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO | K. Pavelka, O. Bruyère, C. Cooper, J. A. Kanis, B. F. Leeb, E. Maheu, J. Martel-Pelletier, J. Monfort, J.-P. Pelletier7, R. Rizzoli, J.-Y. Reginster |
| |
Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases | S. Rozenberg, J.-J. Body, O. Bruyère, P. Bergmann, M. L. Brandi, C. Cooper, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, R. Rizzoli, J.-Y. Reginster |
| |
Effects of glucosamine on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study | L. C. Rovati, F. Girolami, M. D'Amato, G. Giacovelli |
| |
Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys | O. Bruyère, R. D. Altman, J.-Y. Reginster |
| |
Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys | E. Maheu, F. Rannou, J.-Y. Reginster |
| |
Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys | J.-P. Pelletier, J. Martel-Pelletier, F. Rannou, C. Cooper |
| |
Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys | F. Rannou, J.-P. Pelletier, J. Martel-Pelletier |
| |
Optimizing the management of osteoarthritis - Transitioning evidence-based guidelines into practical guidance for real-world clinical practice | J.-Y. Reginster, C. Cooper |
| |
Osteoporosis and sarcopenia: two diseases or one? | J.-Y. Reginster, C. Beaudart, F. Buckinx, O. Bruyère |
| |
Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures | O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster |
| |
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement | J.-Y. Reginster, S. Reiter-Niesert, O. Bruyère, F. Berenbaum, M. L. Brandi, J. Branco, J.-P. Devogelaer, G. Herrero-Beaumont, J. A. Kanis, S. Maggi, E. Maheu, P. Richette, R. Rizzoli, C. Cooper |
| |
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia | J.-Y. Reginster, C. Cooper, R. Rizzoli, J. A. Kanis, G. Appelboom, I. Bautmans, H. A. Bischoff-Ferrari, M. Boers, M. L. Brandi1, O. Bruyère, A. Cherubini, B. Flamion, R. A. Fielding, A. Ildiko Gasparik, L. Van Loon, E. McCloskey, B. H. Mitlak, A. Pilotto, S. Reiter-Niesert, Y. Rolland, Y. Tsouderos, M. Visser, A. J. Cruz-Jentoft |
| |
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club | E. Cavalier, P. Bergmann, O. Bruyère, P. Delanaye, A. Durnez, J.-P. Devogelaer, S. L. Ferrari, E. Gielen, S. Goemaere, J.-M. Kaufman, A. Nzeusseu Toukap, J.-Y. Reginster, A.-F. Rousseau, S. Rozenberg, A. J. Scheen, J.-J. Body |
| |
The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study | J. Runhaar, R. Deroisy, M. van Middelkoop, F. Barretta, B. Barbetta, E. H. Oei, D. Vroegindeweij, G. Giacovelli, O. Bruyère, L. C. Rovati, J.-Y. Reginster, S. M. A. Bierma-Zeinstra |
| |
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia | J.-Y. Reginster, C. Cooper, R. Rizzoli, J. A. Kanis, G. Appelboom, I. Bautmans, H. A. Bischoff-Ferrari, M. Boers, M. L. Brandi, O. Bruyère, A. Cherubini, B. Flamion, R. A. Fielding, A. Ildiko Gasparik, L. Van Loon, E. McCloskey, B. H. Mitlak, A. Pilotto, S. Reiter-Niesert, Y. Rolland, Y. Tsouderos, M. Visser, A. J. Cruz-Jentoft |
| |
Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures | O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster |
| |
Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC) | A. Neuprez, O. Bruyère, E. Maheu, N. Dardenne, N. Burlet, P. D’Hooghe, S. Distèche, J.-Y. Reginster |
| |
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement | J.-Y. Reginster, S. Reiter-Niesert, O. Bruyère, F. Berenbaum, M.-L. Brandi, J. Branco, J.-P. Devogelaer, G. Herrero-Beaumont, J. Kanis, S. Maggi, E. Maheu, P. Richette, R. Rizzoli, C. Cooper |
| |
Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11) | V. Rabenda, O. Bruyère, C. Cooper, R. Rizzoli, F. Buckinx, A. Quabron, J.-Y. Reginster |
| |
Comments on the discordant recommendations for the use of symptomatic slow acting drugs in knee osteoarthritis | J.-Y. Reginster, C. Cooper, M. Hochberg, J.-P. Pelletier, R. Rizzoli, J. A. Kanis, E. Abadie, E. Maheu, M.-L. Brandi, J.-P. Devogelaer, J. Branco, G. Herrero-Beaumont, P. D’Hooghe, O. Bruyère |
| |
The ABC of writing a grant proposal | E. Seeman |
| |
Effects of vitamin D in the elderly population: current status and perspectives | O. Bruyère, E. Cavalier, J.-C. Souberbielle, H. A. Bischoff-Ferrari, C. Beaudart, F. Buckinx, J.-Y. Reginster, R. Rizzoli |
| |
The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials | C. Beaudart, F. Buckinx, V. Rabenda, S. Gillain, E. Cavalier, J. Slomian, J. Petermans, J.-Y. Reginster, O. Bruyère |
| |
Management of osteoporosis of the oldest old | R. Rizzoli, J. Branco, M.-L. Brandi, S. Boonen, O. Bruyère, P. Cacoub, C. Cooper, A. Diez-Perez, J. Duder, R. A. Fielding, N. C. Harvey, M. Hiligsmann, J. A. Kanis, J. Petermans, J. D. Ringe, Y. Tsouderos, J. Weinman, J.-Y. Reginster |
| |
Antiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal Osteoporosis | J. Y. Reginster, A. Neuprez, C. Beaudart, M. P. Lecart, N. Sarlet, D. Bernard, S. Disteche, O. Bruyere |
| |
Challenges for the Development of Bone-Forming Agents in Europe | John A. Kanis, Rene Rizzoli, Cyrus Cooper, Jean-Yves Reginster |
| |
European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions | European Medicines Agency |
| |
Dairy Products: How They Fit in Nutritionally Adequate Diets | Edouard Clerfeuille, MSc; Matthieu Maillot, PhD; Eric O. Verger, MSc; Anne Lluch, PhD; Nicole Darmon, PhD; Nathalie Rolf-Pedersen, PhD |
|
VIII CONGRESSO OrtoMed (SOCIETÀ ITALIANA DI ORTOPEDIA E MEDICINA Induzione alla) | |
| |
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture | Karol Estrada, Unnur Styrkarsdottir, Evangelos Evangelou, Yi-Hsiang Hsu, Emma L Duncan, Evangelia E Ntzani, Ling Oei, Omar M E |
| |
European guidance for the diagnosis and management of osteoporosis in postmenopausal women | J. A. Kanis, E. V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli, J.-Y. Reginster |
| |
Assessing the Impact of Osteoporosis on the Burden of Hip Fractures | Anders Odén, Eugene V. McCloskey, Helena JoJohansson, John A. Kanis |
| |
Treatment of osteoporosis in men | J.-M. Kaufman, J.-Y. Reginster, S. Boonen, M.L. Brandi, C. Cooper, W. Dere, J.-P. Devogelaer, A. Diez-Perez, J.A. Kanis, E. McCloskey, B. Mitlak, E. Orwoll, J.D. Ringe, G. Weryha, R. Rizzoli |
| |
Incidence of Hip Fracture in Barranquilla, Colombia, and the Development of a Colombian FRAX Model | J. J. Jaller-Raad, J. J. Jaller-Char, J. A. Lechuga-Ortiz, E. Navarro-Lechuga, H. Johansson, J. A. Kanis |
| |
Health Technology Assessment in Osteoporosis | Mickael Hiligsmann, John A. Kanis, Juliet Compston, Cyrus Cooper, Bruno Flamion, Pierre Bergmann, Jean-Jacques Body, Steven Boonen, et al. |
| |
Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF | J. A. Kanis, J. D. Adachi, C. Cooper, P. Clark, S. R. Cummings, M. Diaz-Curiel, N. Harvey, M. Hiligsmann, A. Papaioannou, D. D. Pierroz, S. L. Silverman, P. Szulc |
| |
Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK: 2013 update | National Osteoporosis Guideline Group, Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A |
| |
Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women | W. D. Leslie, S. L. Brennan, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis |
| |
Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures | H. Johansson, A. Odén, E. V. McCloskey, J. A. Kanis |
| |
Quality of Life in Sarcopenia and Frailty | René Rizzoli, Jean-Yves Reginster, Jean-François Arnal, Ivan Bautmans, Charlotte Beaudart, Heike Bischoff-Ferrari, Emmanuel Biver, Steven Boonen, Maria-Luisa Brandi, Arkadi Chines, Cyrus Cooper, Sol Epstein, Roger A. Fielding, Bret Goodpaster, John A. Kanis, Jean-Marc Kaufman, Andrea Laslop, Vincenzo Malafarina, Leocadio Rodriguez Mañas, Bruce H. Mitlak, Richard O. Oreffo, Jean Petermans, Kieran Reid, Yves Rolland, Avan Aihie Sayer, Yannis Tsouderos, Marjolein Visser, Olivier Bruyère |
| |
Tools in the Assessment of Sarcopenia | C. Cooper, R. Fielding, M. Visser, L. J. van Loon, Y. Rolland, E. Orwoll, K. Reid, S. Boonen, W. Dere, S. Epstein, B. Mitlak, Y. Tsouderos, A. A. Sayer, R. Rizzoli, J. Y. Reginster, J. A. Kanis |
| |
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? | J-P Pelletier, C Cooper, C Peterfy, J-Y Reginster, M-L Brandi, O Bruyère, R Chapurlat, F Cicuttini, P G Conaghan, M Doherty, H Genant, G Giacovelli, M C Hochberg, D J Hunter, J A Kanis, M Kloppenburg, J-D Laredo, T McAlindon, M Nevitt, J-P Raynauld, R Rizzoli, C Zilkens, F W Roemer, J Martel-Pelletier, A Guermazi |
| |
Development and application of FRAX in the management of osteoporosis in Ireland | BMcGowan, John A. Kanis, H. Johansson, C. Silke, B. Whelan |
| |
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economics Aspects of Osteoporosis and Osetoarthritis (ESCEO) | R. Rizzoli, S. Boonen, M.-L. Brandi, O. Bruyère, C. Cooper, J.A. Kanis, J.-M. Kaufman, J.D. Ringe, G. Weryha, J.-Y. Reginster |
| |
Worldwide uptake of FRAX | J. A. Kanis, H. Johansson, A. Oden, C. Cooper, E. V. McCloskey |
|
Drugs for bone healing | Maria Luisa Brandi |
|
Socioeconomic Burden of Total Joint Arthroplasty for Symptomatic Hip and Knee Osteoarthritis in the Italian Population: A 5-Year Analysis Based on Hospitalization Records | P. PISCITELLI, G. IOLASCON, G. DI TANNA, E. BIZZI, G. CHITANO, A. ARGENTIERO, C. NEGLIA, L. GIOLLI, A. DISTANTE, R. GIMIGLIANO, M. L. BRANDI, AND ALBERTO MIGLIORE |
|
Assessment of Gene-by-Sex Interaction Effect on Bone Mineral Density | Ching-Ti Liu, Karol Estrada, Laura M Yerges-Armstrong, Najaf Amin, Evangelos Evangelou, Guo Li, Ryan L Minster, Melanie A Carless, Candace M Kammerer, Ling Oei, Yanhua Zhou, Nerea Alonso, Zoe Dailiana, Joel Eriksson, Natalia Garci´a-Giralt, Sylvie Giroux, Lise Bjerre Husted, Rita I Khusainova, Theodora Koromila, Annie WaiChee Kung, Joshua R Lewis, Laura Masi......... |
|
When the government actively faces the burden of osteoporosis: the Italian experience | Maria Luisa Brandi, Giuseppe Guglielmi, Salvatore Masala, Salvatore Minisola, Sergio Ortolani, Umberto Tarantino, Giovanni Simonetti |
|
Updated fracture incidence rates for the Italian version of FRAX® | P. Piscitelli, G. Chitano, H. Johannson, M. L. Brandi, J. A. Kanis, D. M. Black |
|
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures | F. Lapi, F. Cipriani, A. P. Caputi, G. Corrao, A. Vaccheri, M. C. Sturkenboom, M. Di Bari, D. Gregori, F. Carle, T. Staniscia, A. Vestri, M. Brandi, V. Fusco, G. Campisi, G. Mazzaglia, on behalf of the Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group |
|
Denosumab Densitometric Changes Assessed by Quantitative Computed Tomography at the Spine and Hip in Postmenopausal Women With Osteoporosis | Michael R. McClung, Jose R. Zanchetta, Arne Høiseth, David L. Kendler, Chui Kin Yuen, Jacques P. Brown, Sigitas Stonkus, Stefan Goemaere, Chris Recknor, Grattan C. Woodson, Michael A. Bolognese, Edward Franek, Maria Luisa Brandi, Andrea Wang, and Cesar Libanati |
|
Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FREEDOM Study | Michael A. Bolognese, Christence Stubbe Teglbjærg, Jose R. Zanchetta, Kurt Lippuner, Michael R. McClung, Maria Luisa Brandi, Arne Høiseth, Peter Lakatos, Alfred H. Moffett, Roman S. Lorenc, Andrea Wang, and Cesar Libanati |
|
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards | S. Vasikaran, R. Eastell, O. Bruyère, A. J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H. A. Morris, S. Silverman, T. Trenti, D. A. Wahl, C. Cooper, J. A. Kanis, for the IOF-IFCC Bone Marker Standards Working Group |
|
Osteoporosis: burden, health care provision and opportunities in the EU | O. Ström, F. Borgström, John A. Kanis, Juliet Compston, Cyrus Cooper, Eugene V. McCloskey, Bengt Jönsson |
|
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report | R. Rizzoli, K. Åkesson, M. Bouxsein, J. A. Kanis, N. Napoli, S. Papapoulos, J.-Y. Reginster, C. Cooper |
|
Validation of the IOF quality of life questionnaire for patients with wrist fracture | P. Lips, K. Jameson, M. L. Bianchi, S. Goemaere, S. Boonen, J. Reeve, J. Stepan, O. Johnell, N. M. van Schoor, E. Dennison, J. A. Kanis, C. Cooper, Working Group for Quality of Life of the International Osteoporosis Foundation |
|
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis | S. Lekamwasam, J. D. Adachi, D. Agnusdei, J. Bilezikian, S. Boonen, F. Borgström, C. Cooper, A. Diez Perez, R. Eastell, L. C. Hofbauer, J. A. Kanis, B. L. Langdahl, O. Lesnyak, R. Lorenc, E. McCloskey, O. D. Messina, N. Napoli, B. Obermayer-Pietsch, S. H. Ralston, P. N. Sambrook, S. Silverman, M. Sosa, J. Stepan, G. Suppan, D. A. Wahl, J. E. Compston, Joint IOF-ECTS GIO Guidelines Working Group |
|
European guidance for the diagnosis and management of osteoporosis in postmenopausal women | J. A. Kanis, N. Burlet, C. Cooper, P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli |
|
Interpretation and use of FRAX in clinical practice | J. A. Kanis, D. Hans, C. Cooper, S. Baim, J. P. Bilezikian, N. Binkley, J. A. Cauley, J. E. Compston, B. Dawson-Hughes, G. El-Hajj Fuleihan, H. Johansson, W. D. Leslie, E. M. Lewiecki, M. Luckey, A. Oden, S. E. Papapoulos, C. Poiana, R. Rizzoli, D. A. Wahl, E. V. McCloskey, Task Force of the FRAX Initiative |
|
European guidance for the diagnosis and management of osteoporosis in postmenopausal women | J. A. Kanis, E. V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli, J.-Y. Reginster |
|
Intrauterine growth and postnatal skeletal development: findings from the Southampton Women’s Surveyppe_1237 | Nicholas C. Harvey, Pam A. Mahon, Miranda Kim, Zoe A. Cole, Sian M. Robinson, Kassim Javaid, Hazel M. Inskip, Keith M. Godfrey, Elaine M. Dennison, Cyrus Cooper, and the SWS Study Group |
|
Different Indices of Fetal Growth Predict Bone Size and Volumetric Density at 4 Years of Age | Nicholas C. Harvey, Pamela A. Mahon, Sian M. Robinson, Corrine E. Nisbet, M. Kassim Javaid, Sarah R. Crozier, Hazel M. Inskip, Keith M. Godfrey, Nigel K. Arden, Elaine M. Dennison, Cyrus Cooper, and the SWS Study Group |
|
Evaluation of Methylation Status of the eNOS Promoter at Birth in Relation to Childhood Bone Mineral Content | Nicholas C. Harvey, Karen A. Lillycrop, Emma Garratt, Allan Sheppard, Cameron McLean, Graham Burdge, Jo Slater-Jefferies, Joanne Rodford, Sarah Crozier, Hazel Inskip, Bright Starling Emerald, Catharine R. Gale, Mark Hanson, Peter Gluckman, Keith Godfrey, Cyrus Cooper |
|
Physical activity, calcium intake and childhood bone mineral: a population-based cross-sectional study | N. C. Harvey, Z. A. Cole, S. R. Crozier, M. Kim, G. Ntani, L. Goodfellow, S. M. Robinson, H. M. Inskip, K. M. Godfrey, E. M. Dennison, N. Wareham, U. Ekelund, C. Cooper |
|
Development and validation of a disease model for postmenopausal osteoporosis | A. Gauthier, J. A. Kanis, M. Martin, J. Compston, F. Borgström, C. Cooper, E. McCloskey |
|
Treatment failure in osteoporosis | A. Diez-Perez, J. D. Adachi, D. Agnusdei, J. P. Bilezikian, J. E. Compston, S. R. Cummings, R. Eastell, E. F. Eriksen, J. Gonzalez-Macias, U. A. Liberman, D. A. Wahl, E. Seeman, J. A. Kanis, C. Cooper |
|
Secular trends in the incidence of hip and other osteoporotic fractures | C. Cooper, Z. A. Cole, C. R. Holroyd, S. C. Earl, N. C. Harvey, E. M. Dennison, L. J. Melton, S. R. Cummings, J. A. Kanis |
|
Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) | C. Cooper, J.-Y. Reginster, B. Cortet, M. Diaz-Curiel, R.S. Lorenc, J.A. Kanis, R. Rizzoli |
|
A fully automated system for quantification of knee bone marrow lesions using MRI and the osteoarthritis initiative cohort | Pierre Dodin, François Abram, Jean-Pierre Pelletier, Johanne Martel-Pelletier |
|
Future therapeutics for osteoarthritis | Johanne Martel-Pelletier, Lukas M. Wildi, Jean-Pierre Pelletier |
|
Reliability and sensitivity to change of IW-TSE versus DESS magnetic resonance imaging sequences in the assessment of bone marrow lesions in knee osteoarthritis patients: Longitudinal data from the Osteoarthritis Initiative (OAI) cohort | Jean-Pierre Raynauld, Lukas Martin Wildi, François Abram, Thomas Moser, Jean-Pierre Pelletier, Johanne Martel-Pelletier |
|
Biologics and the Cardiovascular System: A Double-Edged Sword | Camille Roubille, Johanne Martel-Pelletier, Boulos Haraoui, Jean-Claude Tardif and Jean-Pierre Pelletier |
|
Osteoarthritis treatments: where do we stand at the moment? | Camille Roubille, Johanne Martel-Pelletier, Jean-Pierre Pelletier |
|
Assessment of Cartilage Changes Over Time in Knee Osteoarthritis Disease-Modifying Osteoarthritis Drug Trials Using Semiquantitative and Quantitative Methods: Pros and Cons | Lukas MAartin Wildi, Johanne Martel-Pelletier, François Abram, Thomas Moser, Jean-Pierre Raynauld, and Jean-Pierre Pelletier |
|
How to define responders in osteoarthritis | C. Cooper, J.D. Adachi, T. Bardin, F. Berenbaum, B. Flamion, H. Jonsson, J. A. Kanis, F. Pelousse, W. F. Lems, J.-P. Pelletier, J. Martel-Pelletier, S. Reiter, J.-Y. Reginster, R. Rizzoli, O. Bruyère |
|
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial | J.-Y. Reginster, J. Badurski, N. Bellamy, W. Bensen, R. Chapurlat, X. Chevalier, C. Christiansen, H. Genant, F. Navarro, E. Nasonov, P. N. Sambrook, T. D. Spector, C. Cooper |
|
Understanding Osteoarthritis From Bench to Bedside | Martel-Pelletier, J., Pelletier, J-P.: Editors, In |
|
A fully automated human knee 3D MRI bone segmentation using the ray casting technique | Dodin, P., Martel-Pelletier, J., Pelletier, J-P., Abram, F. |
|
Strontium ranelate inhibits key factors affecting bone remodelling in human osteoarthritic subchondral bone osteoblasts | Tat, S.K., Pelletier, J-P., Mineau, F., Caron, J., Martel-Pelletier, J. |
|
Risk factors predictive of joint replacement in a two-year multicentre clinical trial in knee osteoarthritis using MRI: results from over six years of observation | Raynauld, J-P., Martel-Pelletier, J., Haraoui, B., Choquette, D., Dorais, M., Wildi, L.M., Abram, F., Pelletier, J-P. for the Canadian Licofelone Study Group. |
|
Chondroitin sulphate reducesoth cartilage volume loss and bone marrow lesions in knee OA patients starting as early as 6 months after initiation of therapy: a randomized, double-blind, placebo controlled pilot study using MRI | Wildi, L.M., Raynauld, J-P., Martel-Pelletier, J., Beaulieu, A., Bessette, L., Morin F., Abram, F., Dorais, M., Pelletier J-P. |
|
Trends in Hip Fracture Incidence and in the Prescription of Antiosteoporosis Medications During the Same Time Period in Belgium (2000-2007) | M. Hiligsmann, O. Bruyère, D. Roberfroid, C. Dubois, Yves Parmentier, J. Carton, J. Detilleux, P. Gillet, J.-Y. Reginster |
|
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care | F. Lapia, M. Simonettib, R. Michieli, A. Pasqua, M.L. Brandi, B. Frediani, C. Cricelli, G. Mazzaglia |
|
Genetic architecture of hand quantitative ultrasound measures: A population-based study in a Sardinian genetic isolate | G. Biino, L. Casula, F. de Terlizzi, M. Adamo, S. Vaccargiu, M. Francavilla, D. Loi, A. Casti, M. Atzori, M. Cosso, F. Marras, C. Cepollaro, M. L. Brandi, M. Pirastu |
|
Genetic Determinants of Osteoporosis: Common Bases to Cardiovascular Diseases? | F. Marini, M. L. Brandi |
|
Paget's disease of bone: there's more than the affected skeletal--a clinical review and suggestions for the clinical practice. | A. Falchetti, L. Masi, M. L. Brandi |
|
Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw | F. Marini, P. Tonelli, L. Cavalli, T. Cavalli, L. Masi, A. Falchetti, M. L. Brandi |
|
Pharmacogenetics of osteoporosis | F. Marini, M. L. Brandi |
|
What is a good patient reported outcome after total hip replacement? | N.K. Arden, A. Kiran, A. Judge, L.C. Biant, M.K. Javaid, D.W. Murray, A.J. Carr, C. Cooper, R.E. Field |
|
Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis. | J. Baird, M. A. Kurshid, M. Kim, N. Harvey, E. Dennison, C. Cooper |
|
Facilitated transporters mediate net efflux of amino acids to the fetus across the basal membrane of the placental syncytiotrophoblast | J. K. Cleal, J. D. Glazier, G. Ntani, S. R. Crozier, P. E. Day, N. C. Harvey, S. M. Robinson, C. Cooper, K. M. Godfrey, M. A. Hanson, R. M. Lewis |
|
Increased fat mass is associated with increased bone size but reduced volumetric density in pre pubertal children | Z.A. Cole, N.C. Harvey, M. Kim, G. Ntani, S.M. Robinson, H.M. Inskip, K.M. Godfrey, C. Cooper, E.M. Dennison, The Southampton Women's Survey Study Group |
|
Objective measures of physical capability and subsequent health: a systematic review | R. Cooper, D. Kuh, C. Cooper, C. R. Gale, D. A. Lawlor, F. Matthews, R. Hardy, The Falcon and Halcyon Study Teams |
|
Secular trends in the incidence of hip and other osteoporotic fractures | C. Cooper, Z. A. Cole, C. R. Holroyd, S. C. Earl, N. C. Harvey, E. M. Dennison, L. J. Melton, S. R. Cummings, J. A. Kanis, The IOF CSA Working Group on Fracture Epidemiology |
|
Epigenetic influences in the developmental origins of osteoporosis | C. Holroyd, N. Harvey, E. Dennison, C. Cooper |
|
Growth in childhood predicts hip fracture risk in later life | M. K. Javaid, J. G. Eriksson, E. Kajantie, T. Forsén, C. Osmond, D. J. P. Barker, C. Cooper |
|
Coordinator-based systems for secondary prevention in fragility fracture patients | D. Marsh, K. Akesson, D. E. Beaton, E. R. Bogoch, S. Boonen, M.-L. Brandi, A. R. McLellan, P. J. Mitchell, J. E. M. Sale, D. A. Wahl, IOF CSA Fracture Working Group |
|
Association of vitamin D status with knee pain and radiographic knee osteoarthritis | S. Muraki, E. Dennison, K. Jameson, B.J. Boucher, T. Akune, N. Yoshimura, A. Judge, N.K. Arden, K. Javaid, C. Cooper |
|
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study | S. Pouwels, A. Lalmohamed, P. Souverein, C. Cooper, B. J. Veldt, H. G. Leufkens, A. de Boer, T. van Staa, F. de Vries |
|
Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis | D. Prieto-Alhambra, M. K. Javaid, A. Judge, J. Maskell, A. Kiran, C. Cooper, N. K. Arden |
|
Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study | D. Prieto-Alhambra, M. K. Javaid, J. Maskell, A. Judge, M. Nevitt, C. Cooper, N. K. Arden |
|
Fracture Risk Before and After Total Hip Replacement in Patients With Osteoarthritis | D. Prieto-Alhambra, M. K. Javaid, A. Judge, J. Maskell, A. Kiran, F. de Vries, C. Cooper, N. K. Arden |
|
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report | R. Rizzoli, K. Akesson, M. Bouxsein, J. A. Kanis, N. Napoli, S. Papapoulos, J.-Y. Reginster, C. Cooper |
|
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW) | E. S. Siris, S. Gehlbach, J. D. Adachi, S. Boonen, R. D. Chapurlat, J. E. Compston, C. Cooper, P. Delmas, A. Díez-Pérez, F. H. Hooven, A. Z. LaCroix, J. C. Netelenbos, J. Pfeilschifter, M. Rossini, C. Roux, K. G. Saag, P. Sambrook, S. Silverman, N. B. Watts, A. Wyman, S. L. Greenspan |
|
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards | S. Vasikaran, R. Eastell, O. Bruyère, A. J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H. A. Morris, S. Silverman, T. Trenti, D. A. Wahl, C. Cooper, J. A. Kanis, for the IOF-IFCC Bone Marker Standards Working Group |
|
Life course body mass index and risk of knee osteoarthritis at the age of 53 years: evidence from the 1946 British birth cohort study | A. K. Wills, S. Black, R. Cooper, R. J. Coppack, R. Hardy, K. Remmes Martin, C. Cooper, D. Kuh |
|
A FRAX® model for the assessment of fracture probability in Belgium | H. Johansson, J. A. Kanis, E. V. McCloskey, A. Odén, J.-P. Devogelaer, J.-M. Kaufman,A. Neuprez, M. Hiligsmann, O. Bruyere, J.-Y. Reginster |
|
Adverse Reactions and Drug-Drug Interactions in the Management of Women with Postmenopausal Osteoporosis | R. Rizzoli, J.-Y. Reginster, S. Boonen, G. Bréart, A. Diez-Perez, D. Felsenberg, J.-M. Kaufman, J. A. Kanis, C. Cooper |
|
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies | P. Miossec, C. L. Verweij, L. Klareskog, C. Pitzalis, A. Barton, F. Lekkerkerker, S. Reiter, A. Laslop, F. Breedveld, E. Abadie, B. Flamion, W. Dere, S. Mpofu, N. Goel, D. Ethgen, B. Mitlak, S. Ormarsdóttir, R. Rao, Y. Tsouderos, J.-Y. Reginster; on behalf of the Group for the Respect of Ethics and Excellence in Science (GREES) |
|
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns | B. Dawson-Hughes, A. C. Looker,A. N. A. Tosteson, H. Johansson, J. A. Kanis, L. J. Melton III |
|
Automatic Human Knee Cartilage Segmentation From 3-D Magnetic Resonance Images | P. Dodin, J.-P. Pelletier, J. Martel-Pelletier, F. Abram |
|
Development and validation of a disease model for postmenopausal osteoporosis | A. Gauthier, J. A. Kanis, M. Martin, J. Compston, F. Borgström, C. Cooper, E. McCloskey; On behalf of the Committee of Scientific Advisors, International Osteoporosis Foundation |
|
FRAX - modell för att beräkna 10-årsrisken för fraktur | H. Johansson, J. A. Kanis, Ö. Ljunggren, O. Ström, O. Svensson, D. Mellström |
|
Osteoporosis | J. A. Kanis |
|
Case finding for the management of osteoporosis with FRAX®-assessment and intervention thresholds for the UK | J. A. Kanis, E. V. McCloskey, H. Johansson, O. Ström, F. Borgström, A. Oden, National Osteoporosis Guideline Group |
|
Guidance for the adjustment of FRAX according to the dose of glucocorticoids | J. A. Kanis, H. Johansson, A. Oden, E. V. McCloskey |
|
Development and use of FRAX® in osteoporosis | J. A. Kanis, E. V. McCloskey, H. Johansson, A. Oden, O. Strom, F. Borgstrom |
|
Osteoporosis - Clinical Review | J. A. Kanis, E. V. McCloskey |
|
Towards a diagnostic and therapeutic consensus in male osteoporosis | J. A. Kanis, G. Bianchi, J. P. Bilezikian, J.-M. Kaufman, S. Khosla, E. Orwoll, E. Seeman |
|
Targeting subchondral bone for treating osteoarthritis: what is the evidence? | S. Kwan Tat, D. Lajeunesse, J.-P. Pelletier, J. Martel-Pelletier. |
|
Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement | W. D. Leslie, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis |
|
Independent Clinical Validation of a Canadian FRAX Tool: Fracture Prediction and Model Calibration | W. D. Leslie, L. M. Lix, H. Johansson, A. Oden, E. V. McCloskey, J. A. Kanis for the Manitoba Bone Density Program |
|
Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance | A. C. Looker, B. Dawson-Hughes, A. N. A. Tosteson, H. Johansson, J. A. Kanis, L. J. Melton III |
|
Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis | J.-P. Pelletier, J.-P. Raynauld, J. Caron, F. Mineau, F. Abram, M. Dorais, B. Haraoui, D. Choquette, J. Martel-Pelletier |
|
Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation | J.-P. Raynauld, J. Martel-Pelletier, B. Haraoui, D. Choquette, M. Dorais, L. M. Wildi, F. Abram, J.-P. Pelletier; for the Canadian Licofelone Study Group |
|
Adverse Reactions and Drug-Drug Interactions in the Management of Women with Postmenopausal Osteoporosis | R. Rizzoli, J.-Y. Reginster, S. Boonen, G. Bréart, A. Diez-Perez, D. Felsenberg, J.-M. Kaufman, J. A. Kanis, C. Cooper |
|
Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts | S. Kwan Tat, J.-P. Pelletier, F. Mineau, J. Caron, J. Martel-Pelletier |
|
Hondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI | L. M. Wildi, J.-P. Raynauld, J. Martel-Pelletier, A. Beaulieu, L. Bessette, F. Morin, F. Abram, M. Dorais, J.-P. Pelletier |
|
Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) | O. Bruyère, R. Rizzoli, V. Coxam, B. Avouac, T. Chevalier, V. Fabien-Soulé, J. A. Kanis, J.-M. Kaufman, Y. Tsouderos, J.-Y. Reginster |
|
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) | O. Bruyère, J. A. Kanis, M.-E. Ibar-Abadie, N. Alsayed, M. L. Brandi, N. Burlet, D. L. Cahall, A. Chines, J.-P. Devogelaer, W. Dere, N. Goel, N. Hughes, J.-M. Kaufman, S. Korte, B. H. Mitlak, D. Niese, R. Rizzoli, L. C. Rovati, J.-Y. Reginster |
|
Loading and Skeletal Development and Maintenance | P. Bergmann, J. J. Body, S. Boonen, Y. Boutsen, J.-P. Devogelaer, S. Goemaere, J. Kaufman, J.-Y. Reginster, S. Rozenberg |
|
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA | J. S. Smolen, M. Boers, E. C. Abadie, F. C. Breedveld, P. Emery, T. Bardin, N. Goel, D. J. Ethgen, B. P. Avouac, W. H. Dere, P. Durez, M. Matucci-Cerenic, B. Flamion, A. Laslop |
|
Medication Compliance and Persistence: Terminology and Definitions | J. A. Cramer, A. Roy, A. Burrell, C. J. Fairchild, M. J. Fuldeore, D. A. Ollendorf, P. K. Wong |
|
A Competing Risks Prescription Refill Model of Compliance and Persistence | T. I. Barron, K. Bennett, J. Feely |
|
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club | J.-J Body, P. Bergmann, S. Boonen, Y. Boutsen, J.-P. Devogelaer, S. Goemaere, J.-M. Kaufman, S. Rozenberg, J.-Y. Reginster |
|
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis | R. Rizzoli, N. Burlet, D. Cahall, P. D. Delmas, E. F. Eriksen, D. Felsenberg, J. Grbic, M. Jontell, R. Landesberg, A. Laslop, M. Wollenhaupt, S. Papapoulos, O. Sezer, M. Sprafka, J.-Y. Reginster |
|
The role of calcium and vitamin D in the management of osteoporosis | R. Rizzoli, S. Boonen, M.-L. Brandi, N. Burlet, P. Delmas, J.-Y. Reginster |
|
European regulatory perspectives for innovative therapies | S. Ormarsdottir, J.-Y. Reginster, E. Abadie |
|
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system | O. Bruyère, N. Burlet, P. D. Delmas, R. Rizzoli, C. Cooper and J.-Y. Reginster |
|
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science | J. Compston, D.M. Reid, J. Boisdron, M.-L. Brandi, N. Burlet, D. Cahall, P.D. Delmas, W. Dere, J.-P. Devogelaer, L.A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van Staa, J.-Y. Reginster |
|
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women | O. Bruyere, A. R. Varela, S. Adami, J. Detilleux, V. Rabenda, M. Hiligsmann, J.-Y. Reginster |
|
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity | P. Musette, M. L. Brandi, P. Cacoub, J. M. Kaufman, R. Rizzoli, J.-Y. Reginster |
|
Management of osteoporosis in the elderly | R. Rizzoli, O. Bruyere, J. B. Cannata-Andia, J.-P. Devogelaer, G. Lyritis, J. D. Ringe, B. Vellas, J.-Y. Reginster |
|
Post-fracture management of patients with hip fracture: a perspective | O. Bruyere, M.-L. Brandi, N. Burlet, N. Harvey, G. Lyritis, H. Minne, S. Boonen, J.-Y. Reginster, R. Rizzoli and K. Akesson |
|
European guidance for the diagnosis and management of osteoporosis in postmenopausal women | J. A. Kanis, N. Burlet, C. Cooper, P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli |
|
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women | V. Rabenda, R. Mertens, V. Fabri, J. Vanoverloop, F. Sumkay, C. Vannecke, A. Deswaef, G. A. Verpooten, J.-Y. Reginster |
|
Adherence to treatment of osteoporosis: a need for study | F. Lekkerkerker, J. A. Kanis, N. Alsayed, G. Bouvenot, N. Burlet, D. Cahall, A. Chines, P. Delmas, R.-L. Dreiser, D. Ethgen, N. Hughes, J.-M. Kaufman, S. Korte, G. Kreutz, A. Laslop, B. Mitlak, V. Rabenda, R. Rizzoli, A. Santora, R. Schimmer, Y. Tsouderos, P. Viethel, J.-Y. Reginster |
|
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis | J. Goldhahn, W. H. Scheele, B. Mitlak, E. Abadie, P. Aspenberg, P. Augat, M.-L. Brandi, N. Burlet, A. Chines, P. D. Delmas, I. Dupin-Roger, D. Ethgen, B. Hanson, F. Hartl, J. Kanis, R. Kewalramani, A. Laslop, D. Marsh, S. Ormarsdottir, R. Rizzoli, A. Santora, G. Schmidmaier, M. Wagener, J.-Y. Reginster |
|
Critical Issues in Translational and Clinical Research for the Study of New Technologies to Enhance Bone Repair | J. Goldhahn, B. Mitlak P. Aspenberg, J. Kanis, R. Rizzoli, J.-Y. Reginster |
|
Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture | V. Rabenda, J. Vanoverloop, V. Fabri, R. Mertens, F. Sumkay, C. Vannecke, A. Deswaef, G. A. Verpooten, J.-Y. Reginster |
|
Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence | V. Rabenda, M. Hiligsmann, J.-Y. Reginster |
|
Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures | V. Rabenda, J.-Y. Reginster |
|
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men | J.-Y. Reginster, E. Abadie, P. Delmas, R. Rizzoli, W. Dere, P. der Auwera, B. Avouac, M.-L. Brandi, A. Daifotis, A. Diez-Perez, G. Calvo, O. Johnell, J.-M. Kaufman, G. Kreutz, A. Laslop, F. Lekkerkerker, B. Mitlak, P. Nilsson, J. Orloff, M. Smillie, A. Taylor, Y. Tsouderos, D. Ethgen, B. Flamion |
|
Therapeutic Adherence with Bisphosphonates in the Treatment of Osteoporosis | V. Rabenda, J.-Y. Reginster |
|
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women | O. Bruyere, A. R. Varela, S. Adami, J. Detilleux,V. Rabenda, M. Hiligsmann, J.-Y. Reginster |
|
Biologic therapies and bone loss in rheumatoid arthritis | C. A. F. Zerbini_P. Clark_L. Mendez-Sanchez_R. M. R. Pereira_O. D. Messina_C. R. Uña_J. D. Adachi_W. F. Lems_C. Cooper_N. E. Lane_on behalf IOF CIBS Working Group. |
|
Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia | Charlotte Beaudart, Emmanuel Biver, Jean-Yves Reginster, René Rizzoli, Yves Rolland, Ivan Bautmans, Jean Petermans, Sophie Gillain, Fanny Buckinx, Nadia Dardenne, Olivier Bruyère |
|
Physical function measurements predict mortality in ambulatory older men | Stefanie L. De Buyser, Mirko Petrovic, Youri E. Taes, Kaatje R. C. Toye, Jean-Marc Kaufman and Stefan Goemaere |
|
Three year functional changes and long-termmortality hazard in community-dwelling older men | Stefanie De Buyser, Mirko Petrovic, Youri Taes, Kaatje Toye, Jean-Marc Kaufman, Stefan Goemaere, Bruno Lapauw |
|
Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men | Stefanie L. De Buyser, Mirko Petrovic, Youri E. Taes, Kaatje R. C. Toye, Jean-Marc Kaufman, Bruno Lapauw, Stefan Goemaere |
|
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture | Serge Ferrari, Jean-Yves Reginster, Maria Luisa Brandi, John A. Kanis Jean-Pierre Devogelaer, Jean-Marc Kaufman, Jean-Marc Féron, Andreas Kurth, René Rizzoli |
|
Vitamin D status correction in Saudi Arabia: an experts' consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) | Nasser M. Al-Daghri, Yousef Al-Saleh, Naji Aljohani, Riad Sulimani, Abdulaziz M. Al-Othman, Hanan Alfawaz, Mona Fouda, Fahad Al-Amri, Awad Shahrani, Mohammed Alharbi, Fahad Alshahrani, Waleed Tamimi, Shaun Sabico,Rene Rizzoli Jean-Yves Reginster |